US20210187481A1 - Zirconium oxide module conditioning - Google Patents
Zirconium oxide module conditioning Download PDFInfo
- Publication number
- US20210187481A1 US20210187481A1 US17/197,665 US202117197665A US2021187481A1 US 20210187481 A1 US20210187481 A1 US 20210187481A1 US 202117197665 A US202117197665 A US 202117197665A US 2021187481 A1 US2021187481 A1 US 2021187481A1
- Authority
- US
- United States
- Prior art keywords
- zirconium oxide
- conditioning
- solution
- module
- sorbent module
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/34—Regenerating or reactivating
- B01J20/345—Regenerating or reactivating using a particular desorbing compound or mixture
- B01J20/3475—Regenerating or reactivating using a particular desorbing compound or mixture in the liquid phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0088—Liquid substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
- A61M1/1605—Physical characteristics of the dialysate fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/168—Sterilisation or cleaning before or after use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1694—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid
- A61M1/1696—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid with dialysate regeneration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/0203—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising compounds of metals not provided for in B01J20/04
- B01J20/0211—Compounds of Ti, Zr, Hf
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/0203—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising compounds of metals not provided for in B01J20/04
- B01J20/0274—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising compounds of metals not provided for in B01J20/04 characterised by the type of anion
- B01J20/0292—Phosphates of compounds other than those provided for in B01J20/048
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/06—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising oxides or hydroxides of metals not provided for in group B01J20/04
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
- B01J20/28052—Several layers of identical or different sorbents stacked in a housing, e.g. in a column
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/34—Regenerating or reactivating
- B01J20/3433—Regenerating or reactivating of sorbents or filter aids other than those covered by B01J20/3408 - B01J20/3425
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J49/00—Regeneration or reactivation of ion-exchangers; Apparatus therefor
- B01J49/05—Regeneration or reactivation of ion-exchangers; Apparatus therefor of fixed beds
- B01J49/07—Regeneration or reactivation of ion-exchangers; Apparatus therefor of fixed beds containing anionic exchangers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J49/00—Regeneration or reactivation of ion-exchangers; Apparatus therefor
- B01J49/05—Regeneration or reactivation of ion-exchangers; Apparatus therefor of fixed beds
- B01J49/08—Regeneration or reactivation of ion-exchangers; Apparatus therefor of fixed beds containing cationic and anionic exchangers in separate beds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J49/00—Regeneration or reactivation of ion-exchangers; Apparatus therefor
- B01J49/50—Regeneration or reactivation of ion-exchangers; Apparatus therefor characterised by the regeneration reagents
- B01J49/57—Regeneration or reactivation of ion-exchangers; Apparatus therefor characterised by the regeneration reagents for anionic exchangers
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
- C01B25/26—Phosphates
- C01B25/37—Phosphates of heavy metals
- C01B25/372—Phosphates of heavy metals of titanium, vanadium, zirconium, niobium, hafnium or tantalum
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G25/00—Compounds of zirconium
- C01G25/02—Oxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/10—Apparatus features
- A61L2202/17—Combination with washing or cleaning means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
- A61L2202/20—Targets to be treated
- A61L2202/24—Medical instruments, e.g. endoscopes, catheters, sharps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3324—PH measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
Definitions
- the invention relates to devices, systems, and methods for conditioning a zirconium oxide sorbent module for use in dialysis after recharging.
- the devices, systems, and methods can provide for conditioning and recharging of zirconium oxide in a single system, or in separate systems.
- Zirconium oxide is used in sorbent dialysis to remove anionic wastes from dialysate and to capture phosphate ions that may bleed out of a zirconium phosphate sorbent material. Generally, after use, the zirconium oxide is discarded and replaced. Because zirconium oxide is expensive and rechargeable, sorbent reprocessors can treat the zirconium oxide with strong base solutions to enable reuse of the zirconium oxide material.
- zirconium oxide is generally removed from a sorbent cartridge, separated from other sorbent materials, treated with strong base, and then placed into a new sorbent cartridge.
- the known reprocessing is costly and labor intensive.
- Zirconium oxide treated with strong base will consume total carbonate if used in dialysis, resulting in a basic solution unsafe for patients. Further, to simplify bicarbonate control during dialysis, the zirconium oxide and zirconium phosphate should be in an equilibrium state.
- the first aspect of the invention relates to a method of conditioning zirconium oxide in a zirconium oxide module.
- the method can include the steps of pumping a conditioning solution through the zirconium oxide module in a flow path to condition the zirconium oxide module wherein the conditioning solution has sodium bicarbonate at a desired zirconium oxide effluent pH.
- the method can include the step of recharging the zirconium oxide in the zirconium oxide module prior to conditioning the zirconium oxide module by pumping a base solution through the zirconium oxide module.
- the method can include the step of pumping the conditioning solution through a zirconium phosphate module prior to pumping the conditioning solution through the zirconium oxide module.
- the flow path can be a dialysate flow path including the zirconium phosphate module and zirconium oxide module.
- the flow path can be a recharging flow path including the zirconium phosphate module and zirconium oxide module.
- the desired zirconium oxide effluent pH can be between 5.0 and 7.5.
- the method can include the step of generating the conditioning solution in the flow path.
- the step of generating the conditioning solution can include mixing a sodium bicarbonate solution with acid.
- the step of generating the conditioning solution can include mixing a sodium bicarbonate solution with carbon dioxide.
- the conditioning solution can be pumped through the zirconium oxide module for between 5-30 minutes.
- a volume of the conditioning solution pumped through the zirconium oxide module can be between 0.5 and 20 L.
- the method can include the step of disinfecting the zirconium oxide sorbent module by pumping a disinfectant solution through the zirconium oxide sorbent module.
- the step of generating the conditioning solution can comprise pumping a fluid in a dialysate flow path through a first sorbent module; the first sorbent module containing a solid sodium bicarbonate.
- the second aspect of the invention is drawn to a system.
- the system can include a recharging flow path having at least one receiving compartment for receiving a zirconium oxide module; the at least one receiving compartment having a zirconium oxide module inlet and a zirconium oxide module outlet; a base source fluidly connected to the recharging flow path; a bicarbonate source fluidly connected to the recharging flow path; a pump for pumping fluid from the base source and the bicarbonate source through the zirconium oxide module.
- the system can include an acid source fluidly connected to the recharging flow path.
- the system can include a static mixer in the recharging flow path; wherein the static mixer is fluidly connected to the acid source and the bicarbonate source.
- the system can include a carbon dioxide source fluidly connected to the recharging flow path.
- the carbon dioxide source can be fluidly connected to the bicarbonate source by a fluid connector.
- the system can include a pressure sensor on the fluid connector.
- the system can include a pH sensor in the recharging flow path.
- the system can include at least a second receiving compartment in the recharging flow path for receiving a zirconium phosphate module; the second receiving compartment having a zirconium phosphate module inlet and a zirconium phosphate module outlet and a fluid connector connecting zirconium phosphate module outlet to the zirconium oxide module inlet.
- the system can include an acid source, a brine source, or combinations thereof, fluidly connected to the zirconium phosphate module inlet.
- FIG. 1 shows a flow path for recharging and conditioning a zirconium oxide module.
- FIG. 2 shows a flow path for generating a conditioning solution from a bicarbonate solution and an acid solution.
- FIG. 3 shows a flow path for generating a conditioning solution from a bicarbonate solution and a carbon dioxide source.
- FIG. 4 shows a flow path for generating a conditioning solution from a bicarbonate solution passed through a zirconium phosphate module.
- FIG. 5 shows a flow path for recharging a zirconium phosphate module, as well as recharging and conditioning a zirconium oxide module.
- FIG. 6 shows a dialysate flow path for conditioning a zirconium oxide module during priming.
- FIG. 7 shows a dialysate flow path for conditioning a zirconium oxide module with a solid bicarbonate source.
- FIG. 8 is a flow chart illustrating the steps of recharging and conditioning a zirconium oxide module.
- FIG. 9 shows a recharger for recharging and conditioning of zirconium oxide.
- FIG. 10 shows multiple rechargers chained together for recharging and conditioning multiple zirconium oxide modules.
- an element means one element or over one element.
- An “acid” as used can be a Lewis acid or a Br ⁇ nsted-Lowry acid.
- a Lewis acid is capable of accepting a lone pair of electrons.
- a Br ⁇ nsted-Lowry acid is capable of donating a hydrogen ion to another compound.
- An “acid source” is a fluid or concentrate source from which an acidic solution can be obtained.
- base solution refers to any aqueous solution containing hydroxide ions and a pH of greater than 7.0.
- a “base source” is a fluid or concentrate source from which a base solution can be obtained.
- bicarbonate source refers to a source of bicarbonate ions in solid and/or solution form.
- the bicarbonate ions can be present as a bicarbonate salt of any type.
- the bicarbonate source can contain at least one fluid pathway and include components such as conduits, valves, filters or fluid connection ports, any of which are fluidly connectable to each other or to a fluid flow path.
- the bicarbonate source can either be formed as a stand-alone enclosure or a compartment integrally formed with an apparatus containing the bicarbonate source.
- a “brine source” is a fluid or concentrate source from which a brine solution can be obtained.
- a brine solution can refer to any solution comprising acids, bases and/or salts.
- a “carbon dioxide source” refers to a reservoir, a pressurized cylinder, or tank containing carbon dioxide gas.
- condition or “to condition” refer to processes designed to allow safe and effective use of a component in dialysis.
- a “conditioning solution,” as used herein, is a solution containing bicarbonate ions for use in conditioning a zirconium oxide module.
- a “connector” and “for connection” describe the concept of forming a fluid connection between two components wherein fluid, gas, or mixture of both gas and fluid can flow from one component, through a connector or a component for connection, to another component.
- the connector provides for a fluid connection in its broadest sense and can include any type of tubing, fluid or gas passageway, or conduit between any one or more components of the invention. The connection can optionally be disconnected and then reconnected.
- a “control system” can be a combination of components that act together to maintain a system to a desired set of performance specifications.
- the control system can use processors, memory and computer components configured to interoperate to maintain the desired performance specifications.
- the control system can also include fluid or gas control components, and solute control components as known within the art to maintain the performance specifications.
- deired zirconium oxide effluent pH refers to a preferred pH range for fluid exiting a zirconium oxide module during dialysis.
- determining and “determine” refer to ascertaining a particular state or desired state of a system or variable(s).
- a “dialysate flow path” is a route in which a fluid will travel during dialysis.
- fectant solution refers to any solution capable of destroying or removing bacterial contaminants from a reusable sorbent module.
- disinfecting refers to removing bacterial contaminants from a component or system.
- a “flow path” is one or more connectors or components through which fluid can travel.
- fluid can be any substance that has no fixed shape that yields easily to external pressure such as a gas or a liquid.
- the fluid can be water containing any solutes at any concentration.
- fluidly connectable refers to the ability to pass fluid or gas from one point to another point.
- the two points can be within or between any one or more of compartments, modules, systems, components, and rechargers, all of any type.
- the connection can optionally be disconnected and then reconnected.
- a “fluid connector,” “fluid connection,” and the like describe a connection between two components wherein fluid or gas can flow from one component, through a connector or a component for connection, to another component.
- the connector provides for a fluid connection in its broadest sense and can include any type of tubing, fluid or gas passageway, or conduit between any one or more components of the invention.
- the connection can optionally be disconnected and then reconnected.
- generating or “to generate” refer to creating a fluid with a specified concentration, pH, temperature, and/or volume from one or more fluid sources.
- mixing generally refers to causing two or more fluids from any source to combine together.
- mixing can include turbulent flow at a location in a fluid line or a junction.
- Another example of “mixing” can include receiving one or more fluids in a component configured to receive fluids from one or multiple sources and to mix the fluids together in the component.
- Yet another example of “mixing” includes one or more fluids used in dissolution of one or more solid components to be dissolved in one or more fluids.
- a “module inlet” is a connector through which a fluid, slurry, or aqueous solution can enter a sorbent module.
- a “module outlet” is a connector through which a fluid, slurry, or aqueous solution can exit a sorbent module.
- pH sensor refers to a device for measuring the pH or H + concentration of a liquid in a vessel, container, or fluid line.
- pressure sensor refers to a device for measuring the pressure of a gas or liquid in a vessel, container, or fluid line.
- pump refers to any device that causes the movement of fluids or gases by applying suction or pressure.
- Recharging refers to treating a sorbent material to restore the functional capacity of the sorbent material to put the sorbent material back into a condition for reuse or use in a new dialysis session.
- the total mass, weight and/or amount of “rechargeable” sorbent materials remain the same.
- the total mass, weight and/or amount of “rechargeable” sorbent materials change.
- the recharging process may involve exchanging ions bound to the sorbent material with different ions, which in some instances may increase or decrease the total mass of the system. However, the total amount of the sorbent material will in some instances be unchanged by the recharging process. Upon a sorbent material undergoing “recharging,” the sorbent material can then be said to be “recharged.”
- a “recharging flow path” is a path through which fluid can travel while recharging sorbent material in a reusable sorbent module.
- a “receiving compartment” is a space within a recharger or other apparatus into which a sorbent module to be recharged is placed.
- saturated refers to a solution containing the greatest amount of a solute under given operating conditions.
- solid sodium bicarbonate refers to sodium bicarbonate in the solid phase, and can include either granular, crystalline, or powdered forms, or combinations thereof, of the sodium bicarbonate.
- a “sorbent cartridge module” or “sorbent module” means a discreet component of a sorbent cartridge. Multiple sorbent cartridge modules can be fitted together to form a sorbent cartridge of two, three, or more sorbent cartridge modules. In some embodiments, a single sorbent cartridge module can contain all of the necessary materials for dialysis. In such cases, the sorbent cartridge module can be a “sorbent cartridge.”
- a sorbent “recharger” is an apparatus designed to recharge at least one sorbent material.
- a “static mixer” is a component configured to receive fluids from one or multiple sources and to mix the fluids together.
- the static mixer may include components that agitate the fluids to further mixing.
- Zeroconium oxide also known as hydrous zirconium oxide, is a sorbent material that removes anions from a fluid, exchanging the removed anions for different anions.
- zirconium oxide sorbent module is a sorbent module containing zirconium oxide.
- Zero phosphate is a sorbent material that removes cations from a fluid, exchanging the removed cations for different cations.
- zirconium phosphate sorbent module is a sorbent module containing zirconium phosphate.
- FIG. 1 illustrates a non-limiting embodiment of a recharger flow path for recharging and conditioning of a zirconium oxide sorbent module 102 .
- the zirconium oxide sorbent module 102 can be placed in a receiving compartment of a recharger and fluidly connected to the recharging flow path 101 through zirconium oxide module inlet 103 and zirconium oxide module outlet 104 into effluent line 109 .
- a base solution containing a strong base, such as sodium hydroxide, can be pumped through the zirconium oxide sorbent module 102 from base source 105 fluidly connected to recharging flow path 101 .
- Pump 107 provides a driving force for pumping the fluids through recharging flow path 101 .
- the hydroxide ions in the base solution will displace phosphate and other anions bound to the zirconium oxide during dialysis.
- the zirconium oxide After pumping base solution through the zirconium oxide sorbent module 102 , the zirconium oxide will be substantially saturated with hydroxide ions, and in a state that will consume total carbonate from solutions, including CO 3 2 ⁇ , HCO 3 ⁇ and CO 2 gas.
- the consumption of total carbonate by the zirconium oxide creates a basic dialysate having an unacceptable pH for therapy.
- the zirconium oxide must be conditioned.
- the conditioning process places the zirconium oxide sorbent module 102 in an appropriate chemical state for reuse in dialysis.
- Conditioning of the zirconium oxide with sodium bicarbonate places the zirconium oxide in pH equilibrium with the bicarbonate conditioning solution.
- bicarbonate solution at a predetermined desired zirconium oxide effluent pH is pumped through the zirconium oxide sorbent module 102 from bicarbonate source 106 fluidly connected to recharging flow path 101 .
- Valve 108 controls the movement of fluid from the base source 105 and bicarbonate source 106 through the recharging flow path 101 .
- additional or alternative fluid sources can be included for recharging and conditioning of the zirconium oxide sorbent module 102 .
- a disinfectant source (not shown) containing a disinfectant solution such as bleach, peracetic acid, citric acid, or any other disinfectant known in the art, can be included for disinfecting the zirconium oxide sorbent module 102 prior to reuse.
- the zirconium oxide sorbent module 102 can be disinfected with bleach, peracetic acid, citric acid, or any other disinfectant by pumping a disinfectant solution through the zirconium oxide sorbent module 102 at the beginning of the recharging and conditioning process, after conditioning and recharging, or in parallel with any of the conditioning or recharging steps.
- the zirconium oxide sorbent module 102 can be disinfected and recharged in parallel by using a combined base and bleach solution.
- the zirconium oxide sorbent module 102 can be disinfected and conditioned in parallel by using a combined bicarbonate and bleach solution at the desired zirconium oxide effluent pH.
- a water source (not shown) can be included for rinsing or flushing the zirconium oxide sorbent module 102 before or after disinfection or recharging or conditioning.
- the conditioning solution is pumped through the zirconium oxide sorbent module 102 for a sufficient length of time to ensure complete conditioning.
- the conditioning solution can be pumped through the zirconium oxide sorbent module 102 for any length of time including between any of 5 and 30 minutes, 5 and 10 minutes, 5 and 8 minutes, 7 and 10 minutes, 8 and 12 minutes, 10 and 15 minutes, 10 and 30 minutes, 15 and 25 minutes, or 20 and 30 minutes.
- the zirconium oxide sorbent module 102 is used with zirconium phosphate and other sorbent materials for regeneration of dialysate.
- equilibration of the zirconium oxide module with the zirconium phosphate is desired.
- the equilibration of zirconium phosphate and zirconium oxide means the pH of the zirconium oxide and zirconium phosphate effluents during therapy are the same.
- a desired zirconium phosphate effluent pH is determined to be 6.5
- the desired zirconium oxide effluent pH can also be 6.5 and the conditioning process can use a bicarbonate solution at a pH of 6.5 to place the zirconium phosphate and zirconium oxide sorbent modules in an equilibrium state.
- the zirconium oxide can be conditioned to any desired zirconium oxide effluent pH by using a bicarbonate solution at the desired zirconium oxide effluent pH.
- the bicarbonate in bicarbonate source 106 can include bicarbonate ions in solid and/or solution form.
- a bicarbonate dry cartridge may be included in bicarbonate source 106 .
- Water can be added to the bicarbonate source 106 to dissolve the bicarbonate in the dry cartridge, or flowed through the dry cartridge, generating a bicarbonate solution of known concentration for use in conditioning.
- bicarbonate source 106 can include a premade bicarbonate solution.
- the concentration of the bicarbonate in bicarbonate source 106 can be any concentration leading to a desired zirconium oxide effluent pH.
- the concentration of bicarbonate used in conditioning the zirconium oxide can be between 0.1 M and saturated, between 0.1 M and 1.0 M, between 0.5 M and 1.0 M, between 0.5 M and 2.0 M, between 1.0 M and saturated, or between 2.0 and saturated.
- the desired zirconium oxide effluent pH can be any pH, and in a preferred embodiment is between 5.0 and 7.5.
- the desired zirconium effluent pH can be between any of 5.0 and 6.0, between 5.0 and 6.5, between 5.5 and 6.5, between 5.5 and 7.0, between 6.0 and 7.5, or between 6.5 and 7.5.
- the conditioning solution can be heated to a specified temperature while conditioning the zirconium oxide.
- the conditioning solution can be heated to any temperature between 20 and 100° C., including between 20 and 35° C., between 20 and 50° C., between 40 and 60° C., between 40 and 80° C., between 50 and 75° C., or between 50 and 100° C.
- the bicarbonate solution can be a 1M bicarbonate solution at a pH of 6.5, requiring 1.3 L of conditioning solution. At higher concentrations, less conditioning solution will be required.
- the concentration and volume of the bicarbonate conditioning solution used can be based on the desired zirconium oxide effluent pH and the pressure capabilities of the system.
- the conditioning solution used can be any volume, including between any of 0.5 and 20.0 L, 0.5 and 1.0 L, 0.75 and 1.25 L, 1.0 and 1.5 L, 1.0 and 5.0 L, 2.5 and 7.5 L, 5.0 and 15.0 L, 5.0 and 20.0 L, or 10.0 and 20.0 L.
- recharging flow path 101 is illustrated as a flow path for both recharging and conditioning a zirconium oxide sorbent module 102 , one of skill in the art will understand that a separate conditioning apparatus can be constructed without base source 105 solely for conditioning of the zirconium oxide sorbent module 102 .
- the conditioning solution containing sodium bicarbonate at a desired zirconium oxide effluent pH can be provided in a pre-mixed bicarbonate source 106 at the proper pH, as illustrated in FIG. 1 .
- the conditioning solution can be generated by the system.
- FIG. 2 illustrates a system for generating the conditioning solution.
- a zirconium oxide sorbent module 202 can be placed in a receiving compartment of a recharger or separate conditioning apparatus and connect to flow path 201 through zirconium oxide sorbent module inlet 203 and zirconium oxide sorbent module outlet 204 into effluent line 209 .
- sodium bicarbonate from bicarbonate source 205 can be mixed with an acid from acid source 206 .
- the acid in acid source 206 can be any acid, including acetic acid, hydrochloric acid, or any other acid known in the art.
- the concentrations of bicarbonate in bicarbonate source 205 and acid in acid source 206 can be set to generate a conditioning fluid having a desired zirconium oxide effluent pH when mixed in flow path 201 .
- a static mixer (not shown) can be included in flow path 201 to ensure mixing of the acid and bicarbonate. Alternatively, the acid and bicarbonate can be mixed through mixing of the fluid streams at the junction between the two lines.
- a pH sensor 208 ensures the pH of the mixed conditioning solution is within an acceptable range of the desired zirconium oxide effluent pH.
- Valves can be included to control the movement of fluid from the bicarbonate source 205 and acid source 206 , allowing a customizable conditioning solution having a variable pH controlled by the relative amounts of bicarbonate and acid used.
- a base source (not shown) can be included in the flow path 201 of FIG. 2 for recharging the zirconium oxide sorbent module 202 prior to conditioning in a single system.
- a separate recharger can recharge the zirconium oxide sorbent module 202 , and conditioning carried out with a different apparatus.
- FIG. 3 illustrates an alternative method of generating a conditioning solution using carbon dioxide gas from carbon dioxide source 306 .
- a zirconium oxide sorbent module 302 can be placed in a receiving compartment of a recharger or conditioning apparatus and connect to flow path 301 through zirconium oxide module inlet 303 and zirconium oxide module outlet 304 into effluent line 309 .
- Pump 307 provides a driving force for moving fluid through the flow path 301 .
- a bicarbonate source 305 fluidly connected to flow path 301 can contain a bicarbonate solution at a higher pH.
- Carbon dioxide gas from carbon dioxide source 306 can be metered into the bicarbonate source 305 through a fluid connector to create a bicarbonate solution having a desired zirconium oxide effluent pH.
- Pressure regulator 308 controls the flow of carbon dioxide gas to the bicarbonate source 305 , allowing control over the pH of the fluid after mixing.
- a pressure sensor (not shown) ensures the correct pressure of carbon dioxide is delivered to the bicarbonate source 305 .
- a pH sensor (not shown) can ensure the pH of the generated solution is at the desired zirconium oxide effluent pH.
- a base source (not shown) can be included in the flow path 301 of FIG. 3 for recharging the zirconium oxide sorbent module 302 prior to conditioning in a single system. Alternatively, a separate recharger can recharge the zirconium oxide sorbent module 302 , and conditioning carried out with a different apparatus.
- FIG. 4 illustrates a flow path 401 with a zirconium phosphate sorbent module 406 for generating the conditioning solution.
- the zirconium oxide sorbent module 402 can be placed in a receiving compartment of a recharger or conditioning apparatus and connect to the flow path 401 through zirconium oxide module inlet 403 and zirconium oxide module outlet 404 into effluent line 410 .
- Pump 407 provides a driving force for pumping fluid through the flow path 401 .
- Bicarbonate source 405 fluidly connected to flow path 401 , can contain bicarbonate at any pH.
- a second receiving compartment can receive a zirconium phosphate sorbent module 406 .
- the bicarbonate solution passes through zirconium phosphate sorbent module 406 , connected by a fluid connector to the flow path 401 through zirconium phosphate module inlet 409 and zirconium phosphate module outlet 408 .
- the bicarbonate conditioning solution will equilibrate with the zirconium phosphate sorbent module 406 , generating a bicarbonate solution with a pH dependent upon the relative amounts of hydrogen and sodium loaded onto the zirconium phosphate sorbent module 406 .
- the zirconium phosphate sorbent module 406 is the same zirconium phosphate sorbent module used with the zirconium oxide sorbent module 402 in dialysis, or is loaded with hydrogen and sodium ions in the same ratio as the zirconium phosphate sorbent module used in dialysis, then the pH of the conditioning solution exiting zirconium phosphate sorbent module 406 will be at the desired equilibrium pH.
- a base source (not shown) can be included in the flow path 401 of FIG. 4 for recharging the zirconium oxide sorbent module 402 prior to conditioning in a single system.
- a separate recharger can recharge the zirconium oxide sorbent module 402 , and conditioning carried out with a different apparatus.
- the zirconium phosphate sorbent module 406 illustrated in FIG. 4 can be a dedicated zirconium phosphate sorbent module, or a zirconium phosphate sorbent module that will be removed from the flow path 401 and used in subsequent dialysis.
- a dedicated zirconium phosphate sorbent module can generate the conditioning solution through multiple cycles before being recharged or replaced. Approximately 150 g of zirconium phosphate is necessary for conditioning of a zirconium oxide module.
- a larger zirconium phosphate sorbent module can be used for multiple conditioning cycles without recharging.
- a zirconium phosphate sorbent module containing 1,500 g of zirconium phosphate can be used for approximately 10 conditioning cycles before being replaced or recharged. Any size zirconium phosphate sorbent module can be used for conditioning the zirconium oxide sorbent modules.
- FIG. 5 illustrates a recharging flow path 500 for recharging both zirconium phosphate and zirconium oxide, with the recharged zirconium phosphate sorbent module 506 used to generate the conditioning solution.
- the zirconium oxide sorbent module 502 can be placed in a receiving compartment of the recharger and connect to a zirconium oxide recharging flow path 501 through zirconium oxide module inlet 503 and zirconium oxide module outlet 504 into effluent line 520 .
- Pump 511 provides a driving force for moving fluid through the zirconium oxide recharging flow path 501 .
- Base solution from base source 505 can be pumped through valve 512 and through zirconium oxide sorbent module 502 to recharge the zirconium oxide.
- the recharger can also have a second receiving compartment for receiving a zirconium phosphate sorbent module 506 , which can connect to zirconium phosphate recharging flow path 519 through zirconium phosphate module inlet 507 and zirconium phosphate module outlet 508 .
- the zirconium phosphate sorbent module 506 is recharged by pumping a brine solution from brine source 509 through valve 514 and zirconium phosphate sorbent module 506 .
- the brine solution can contain acids, bases, salts, or combinations thereof.
- the hydrogen and sodium ions in the brine solution displace potassium, calcium, magnesium, ammonium, and other cations adsorbed by the zirconium phosphate during dialysis.
- Pump 513 provides a driving force for moving fluid through zirconium phosphate recharging flow path 519 .
- the effluent exiting zirconium phosphate sorbent module outlet 508 can pass through valve 515 to drain line 517 to waste reservoir 516 or a drain (not shown).
- the basic effluent exiting zirconium oxide sorbent module 502 can be pumped to the same waste reservoir 516 , drain (not shown) or collected separately for in a separate waste reservoir (not shown) for later disposal.
- the zirconium oxide sorbent module 502 can be conditioned.
- Bicarbonate solution from bicarbonate source 510 can be pumped through the zirconium phosphate sorbent module 506 , generating a bicarbonate solution at the desired zirconium oxide effluent pH.
- Valve 515 can be switched to direct the bicarbonate solution into fluid connector 518 and to valve 512 in the zirconium oxide recharging flow path 501 .
- the bicarbonate solution is pumped from valve 512 through the zirconium oxide sorbent module 502 to condition the zirconium oxide sorbent module 502 .
- FIGS. 1-5 illustrate various methods of conditioning a recharged zirconium oxide sorbent module in either a recharger or a separate conditioning system.
- the recharged zirconium oxide sorbent module can also be conditioned in a dialysate flow path 601 during priming of the system, as illustrated in FIG. 6 .
- FIG. 6 is a simplified diagram of a dialysate flow path 601 .
- dialysate is pumped through the dialysate flow path 601 and dialyzer 605 .
- Pump 604 provides the driving force for pumping fluid through the dialysate flow path 601 .
- blood is pumped through the dialyzer 605 on the opposite side of a semipermeable membrane 606 .
- Waste products in the blood of the patient cross the semipermeable membrane 606 and enter the dialysate in the dialyzer 605 .
- the waste products are removed from the dialysate by a sorbent cartridge 609 , which includes a zirconium phosphate sorbent module 603 and a zirconium oxide sorbent module 602 .
- a sorbent cartridge 609 which includes a zirconium phosphate sorbent module 603 and a zirconium oxide sorbent module 602 .
- additional materials can be included in the sorbent cartridge 609 , such as activated carbon, urease, and alumina (not shown).
- a solution containing sodium bicarbonate is pumped through the dialysate flow path 601 , the dialyzer 605 , and the sorbent cartridge 609 .
- the solution can also contain sodium chloride.
- the method can use a sodium bicarbonate solution followed by a sodium chloride solution, or a sodium chloride solution followed by a sodium bicarbonate solution.
- Water from a water source (not shown), sodium chloride from a sodium chloride source (not shown) are added to the dialysate flow path 601 , and sodium bicarbonate from bicarbonate source 607 is added to the dialysate flow path 601 by pump 608 .
- the resulting priming solution is pumped through the dialysate flow path 601 to prime the system.
- the priming solution containing bicarbonate
- the priming solution is pumped through zirconium phosphate sorbent module 603 , generating a bicarbonate solution at the desired zirconium oxide effluent pH, and then through zirconium oxide sorbent module 602 , conditioning the zirconium oxide sorbent module 602 .
- the priming solution can be recirculated within dialysate flow path 601 in order to maximize the utilization of bicarbonate.
- one pass of fluid through the dialysate flow path 601 can be conducted with adding bicarbonate, and a second pass of the fluid can be done without adding additional bicarbonate.
- Conditioning the zirconium oxide sorbent module 602 during priming requires additional bicarbonate in the dialysis system and lengthens the time necessary for priming.
- the additional amount of bicarbonate solution needed for conditioning during priming can be about 80 to 120 g of sodium bicarbonate.
- Conditioning the zirconium oxide sorbent module 602 during priming also adds between 5-15 minutes to the priming process.
- Conditioning the zirconium oxide sorbent module 602 in a recharger or a separate conditioning system allows a smaller bicarbonate source for therapy and a faster priming process.
- the zirconium oxide sorbent module 602 can be conditioned partly in a recharger or conditioning system, and partly during priming, reducing the additional bicarbonate necessary during priming of the system.
- excess sodium bicarbonate can be rinsed into drain line 609 by pump 610 or used in subsequent priming steps.
- the drain line 609 can be fluidly connected to a drain reservoir 611 , or alternatively, directly to a drain (not shown).
- FIG. 7 is an alternative simplified diagram of a dialysate flow path 701 .
- dialysate is pumped through the dialysate flow path 701 and dialyzer 705 .
- Pump 704 provides the driving force for pumping fluid through the dialysate flow path 701 .
- blood is pumped through the dialyzer 705 on the opposite side of a semipermeable membrane 706 . Waste products in the blood of the patient can cross the semipermeable membrane 706 and enter the dialysate in the dialyzer 705 .
- the waste products are removed from the dialysate by a sorbent cartridge 709 , which includes a zirconium phosphate sorbent module 710 , a zirconium oxide sorbent module 702 , and an additional sorbent module 703 .
- the additional sorbent module 703 can contain a solid sodium bicarbonate or powder, which can be used to generate the conditioning solution in the dialysate flow path 701 .
- additional materials can be included in the sorbent cartridge 709 , such as activated carbon, urease, and alumina (not shown). In certain embodiments, activated carbon, urease, and alumina can be contained in sorbent module 703 with the bicarbonate.
- the solid sodium bicarbonate can be placed in the same sorbent module 710 as the zirconium phosphate.
- a solution containing sodium chloride is pumped through the dialysate flow path 701 , the dialyzer 705 , and the sorbent cartridge 709 .
- Water from a water source (not shown) and optionally sodium chloride from a sodium chloride source (not shown) can be added to the dialysate flow path 701 .
- the fluid while flowing through sorbent module 703 , can dissolve the sodium bicarbonate within sorbent module 703 to generate a priming and conditioning solution containing sodium bicarbonate.
- the conditioning solution can also contain sodium chloride.
- the method can generate a sodium bicarbonate solution, followed by a sodium chloride solution.
- a solid sodium bicarbonate in the sorbent module 703 the size requirements for bicarbonate source 707 are reduced, and the priming and conditioning time is reduced.
- the resulting priming solution is pumped through the dialysate flow path 701 to prime the system.
- the priming solution, containing bicarbonate dissolved by fluid passing through sorbent module 703 is pumped through zirconium phosphate sorbent module 710 , generating a bicarbonate solution at the desired zirconium oxide effluent pH, and then through zirconium oxide sorbent module 702 , conditioning the zirconium oxide sorbent module 702 .
- Conditioning the zirconium oxide sorbent module 702 with a conditioning solution formed by dissolving solid sodium bicarbonate in sorbent module 703 requires a quantity of sodium bicarbonate to be initially present in the sorbent module 703 .
- the amount of bicarbonate present in sorbent module 703 can be any amount sufficient to fully condition the zirconium oxide sorbent module 702 .
- the amount of sodium bicarbonate placed in sorbent module 703 can be between 40 and 130 grams, between 40 and 60 grams, between 50 and 100 grams, between 50 and 130 grams, between 75 and 100 grams, or between 80 and 130 grams.
- the necessary amount of sodium bicarbonate can vary depending on the size of zirconium oxide sorbent module 702 .
- an excess of sodium bicarbonate beyond that necessary for conditioning zirconium oxide sorbent module 702 can be placed in sorbent module 703 .
- the excess bicarbonate can be rinsed from the dialysate flow path 701 into drain line 711 by pump 712 or used in subsequent priming steps.
- the bicarbonate solution can be recirculated within dialysate flow path 701 in order to maximize the utilization of bicarbonate during priming.
- the drain line 711 can be fluidly connected to a drain reservoir 713 , or alternatively, directly to a drain (not shown).
- the pH of the conditioning solution can be the same pH as the effluent from the zirconium phosphate sorbent module subsequently used in dialysis.
- FIG. 8 is a flow chart illustrating the steps of recharging and conditioning a zirconium oxide sorbent module to the correct pH.
- a desired zirconium oxide effluent pH can be determined.
- the zirconium oxide sorbent module is recharged with a strong base.
- the conditioning solution is generated.
- any of the described methods for generating the conditioning solution can be used in step 803 , including mixing a bicarbonate solution with acid, mixing a bicarbonate solution with carbon dioxide, pumping a bicarbonate solution through a dedicated or non-dedicated zirconium phosphate sorbent module either in a recharger, a conditioning system, or a dialysate flow path, or pumping water through a sorbent module containing solid sodium bicarbonate in a dialysate flow path.
- the conditioning solution is pumped through the zirconium oxide sorbent module.
- the zirconium oxide sorbent module is reused in dialysis.
- FIG. 9 illustrates a non-limiting embodiment of a recharger for recharging and conditioning zirconium oxide in a zirconium oxide module.
- the recharger 901 includes a zirconium oxide receiving compartment 904 for receiving a zirconium oxide sorbent module 905 .
- the recharger 901 can also have a zirconium phosphate receiving compartment 902 for receiving a zirconium phosphate sorbent module 903 .
- the zirconium phosphate sorbent module 903 can be a dedicated zirconium phosphate sorbent module, or a zirconium phosphate sorbent module that will be used in a subsequent dialysis session.
- the conditioning solution can be pumped through the zirconium phosphate sorbent module 903 and then into the zirconium oxide sorbent module 905 for conditioning.
- the conditioning solution can be generated or stored separately, and need not pass through the zirconium phosphate sorbent module 903 .
- Door 907 controls access to the receiving compartments 902 and 904 during operation.
- a base source and a bicarbonate source (not shown) can be fluidly connected to the recharger 901 for recharging and conditioning of the zirconium oxide sorbent module 905 . Fluid connections (not shown in FIG.
- a brine source (not shown) can also be provided for recharging the zirconium phosphate sorbent module 903 .
- a user interface 906 is provided to start or control the recharging and conditioning processes by the user. The user interface 906 also provides the status of the recharging and conditioning processes to the user, such as the times of completion of each step, or a time until the processes are complete. User interface 906 also provides alert messages if any problems are detected during recharging, such as leaks, occlusions, pump failures, or mismatched chemicals. User interface 906 also allows the user to input the desired zirconium oxide effluent pH to control the conditioning process.
- the recharger 901 can be similarly constructed with solely a zirconium oxide receiving compartment. As described, the conditioning solution can be generated separately, and need not pass through a zirconium phosphate sorbent module.
- the rechargers can have any number of receiving compartments for any combination of zirconium oxide and zirconium phosphate sorbent modules, including 1, 2, 3, 4, 5, 6, 7 or more receiving compartments for recharging and conditioning of any number of zirconium oxide modules.
- a first recharger 1001 having a zirconium phosphate receiving compartment 1003 and zirconium oxide receiving compartment 1002 is fluidly connected to water source 1007 , bicarbonate source 1008 , disinfectant source 1009 , and base source 1010 .
- the zirconium phosphate module used can be a dedicated zirconium phosphate sorbent module, or a zirconium phosphate sorbent module that will be used in subsequent dialysis.
- a brine source (not shown) can be included for zirconium phosphate recharging.
- a second recharger 1004 having a zirconium oxide receiving compartment 1005 and zirconium phosphate receiving compartment 1006 is also fluidly connected to the same water source 1007 , bicarbonate source 1008 , disinfectant source 1009 , and base source 1010 .
- Any number of rechargers can be connected to a common set of fluid sources, including 2, 3, 4, 5, 6 or more rechargers, each fluidly connected to a single set of fluid sources and a single set of waste reservoirs.
- Each of the rechargers may include a separate drain line and/or separate waste reservoirs, or each recharger may be fluidly connected to a common drain line.
- the drain line can also be fluidly connected to any one of a drain, a common reservoir, or combinations thereof.
- the rechargers can alternatively only have zirconium oxide receiving compartments for recharging and conditioning solely of zirconium oxide.
Abstract
Description
- This application claims priority to U.S. application Ser. No. 15/798,233 filed Oct. 30, 2017, which claims the benefit of and priority to U.S. Provisional Patent Application No. 62/427,806 filed Nov. 29, 2016, the entire disclosures of each of which are incorporated by reference herein.
- The invention relates to devices, systems, and methods for conditioning a zirconium oxide sorbent module for use in dialysis after recharging. The devices, systems, and methods can provide for conditioning and recharging of zirconium oxide in a single system, or in separate systems.
- Zirconium oxide is used in sorbent dialysis to remove anionic wastes from dialysate and to capture phosphate ions that may bleed out of a zirconium phosphate sorbent material. Generally, after use, the zirconium oxide is discarded and replaced. Because zirconium oxide is expensive and rechargeable, sorbent reprocessors can treat the zirconium oxide with strong base solutions to enable reuse of the zirconium oxide material.
- For reprocessing, zirconium oxide is generally removed from a sorbent cartridge, separated from other sorbent materials, treated with strong base, and then placed into a new sorbent cartridge. The known reprocessing is costly and labor intensive.
- Zirconium oxide treated with strong base will consume total carbonate if used in dialysis, resulting in a basic solution unsafe for patients. Further, to simplify bicarbonate control during dialysis, the zirconium oxide and zirconium phosphate should be in an equilibrium state.
- Hence, there is a need for systems and methods to condition recharged zirconium oxide to place the zirconium oxide in a state for use in dialysis. There is a further need for systems and methods that can recharge and condition the zirconium oxide within a sorbent module. There is an additional need for systems and methods to condition a recharged zirconium oxide module to an equilibrium state with a zirconium phosphate module for later use in dialysis.
- The first aspect of the invention relates to a method of conditioning zirconium oxide in a zirconium oxide module. In any embodiment, the method can include the steps of pumping a conditioning solution through the zirconium oxide module in a flow path to condition the zirconium oxide module wherein the conditioning solution has sodium bicarbonate at a desired zirconium oxide effluent pH.
- In any embodiment, the method can include the step of recharging the zirconium oxide in the zirconium oxide module prior to conditioning the zirconium oxide module by pumping a base solution through the zirconium oxide module.
- In any embodiment, the method can include the step of pumping the conditioning solution through a zirconium phosphate module prior to pumping the conditioning solution through the zirconium oxide module.
- In any embodiment, the flow path can be a dialysate flow path including the zirconium phosphate module and zirconium oxide module.
- In any embodiment, the flow path can be a recharging flow path including the zirconium phosphate module and zirconium oxide module.
- In any embodiment, the desired zirconium oxide effluent pH can be between 5.0 and 7.5.
- In any embodiment, the method can include the step of generating the conditioning solution in the flow path.
- In any embodiment, the step of generating the conditioning solution can include mixing a sodium bicarbonate solution with acid.
- In any embodiment, the step of generating the conditioning solution can include mixing a sodium bicarbonate solution with carbon dioxide.
- In any embodiment, the conditioning solution can be pumped through the zirconium oxide module for between 5-30 minutes.
- In any embodiment, a volume of the conditioning solution pumped through the zirconium oxide module can be between 0.5 and 20 L.
- In any embodiment, the method can include the step of disinfecting the zirconium oxide sorbent module by pumping a disinfectant solution through the zirconium oxide sorbent module.
- In any embodiment, the step of generating the conditioning solution can comprise pumping a fluid in a dialysate flow path through a first sorbent module; the first sorbent module containing a solid sodium bicarbonate.
- The features disclosed as being part of the first aspect of the invention can be in the first aspect of the invention, either alone or in combination, or follow a preferred arrangement of one or more of the described elements.
- The second aspect of the invention is drawn to a system. In any embodiment the system can include a recharging flow path having at least one receiving compartment for receiving a zirconium oxide module; the at least one receiving compartment having a zirconium oxide module inlet and a zirconium oxide module outlet; a base source fluidly connected to the recharging flow path; a bicarbonate source fluidly connected to the recharging flow path; a pump for pumping fluid from the base source and the bicarbonate source through the zirconium oxide module.
- In any embodiment, the system can include an acid source fluidly connected to the recharging flow path.
- In any embodiment, the system can include a static mixer in the recharging flow path; wherein the static mixer is fluidly connected to the acid source and the bicarbonate source.
- In any embodiment, the system can include a carbon dioxide source fluidly connected to the recharging flow path.
- In any embodiment, the carbon dioxide source can be fluidly connected to the bicarbonate source by a fluid connector.
- In any embodiment, the system can include a pressure sensor on the fluid connector.
- In any embodiment, the system can include a pH sensor in the recharging flow path.
- In any embodiment, the system can include at least a second receiving compartment in the recharging flow path for receiving a zirconium phosphate module; the second receiving compartment having a zirconium phosphate module inlet and a zirconium phosphate module outlet and a fluid connector connecting zirconium phosphate module outlet to the zirconium oxide module inlet.
- In any embodiment, the system can include an acid source, a brine source, or combinations thereof, fluidly connected to the zirconium phosphate module inlet.
- The features disclosed as being part of the second aspect of the invention can be in the second aspect of the invention, either alone or in combination, or follow a preferred arrangement of one or more of the described elements.
-
FIG. 1 shows a flow path for recharging and conditioning a zirconium oxide module. -
FIG. 2 shows a flow path for generating a conditioning solution from a bicarbonate solution and an acid solution. -
FIG. 3 shows a flow path for generating a conditioning solution from a bicarbonate solution and a carbon dioxide source. -
FIG. 4 shows a flow path for generating a conditioning solution from a bicarbonate solution passed through a zirconium phosphate module. -
FIG. 5 shows a flow path for recharging a zirconium phosphate module, as well as recharging and conditioning a zirconium oxide module. -
FIG. 6 shows a dialysate flow path for conditioning a zirconium oxide module during priming. -
FIG. 7 shows a dialysate flow path for conditioning a zirconium oxide module with a solid bicarbonate source. -
FIG. 8 is a flow chart illustrating the steps of recharging and conditioning a zirconium oxide module. -
FIG. 9 shows a recharger for recharging and conditioning of zirconium oxide. -
FIG. 10 shows multiple rechargers chained together for recharging and conditioning multiple zirconium oxide modules. - Unless defined otherwise, all technical and scientific terms used have the same meaning as commonly understood by one of ordinary skill in the art.
- The articles “a” and “an” are used to refer to one or to over one (i.e., to at least one) of the grammatical object of the article. For example, “an element” means one element or over one element.
- An “acid” as used can be a Lewis acid or a Brønsted-Lowry acid. A Lewis acid is capable of accepting a lone pair of electrons. A Brønsted-Lowry acid is capable of donating a hydrogen ion to another compound.
- An “acid source” is a fluid or concentrate source from which an acidic solution can be obtained.
- The term “base solution” refers to any aqueous solution containing hydroxide ions and a pH of greater than 7.0.
- A “base source” is a fluid or concentrate source from which a base solution can be obtained.
- The term “bicarbonate source” refers to a source of bicarbonate ions in solid and/or solution form. The bicarbonate ions can be present as a bicarbonate salt of any type. The bicarbonate source can contain at least one fluid pathway and include components such as conduits, valves, filters or fluid connection ports, any of which are fluidly connectable to each other or to a fluid flow path. The bicarbonate source can either be formed as a stand-alone enclosure or a compartment integrally formed with an apparatus containing the bicarbonate source.
- A “brine source” is a fluid or concentrate source from which a brine solution can be obtained. As used herein, a brine solution can refer to any solution comprising acids, bases and/or salts.
- A “carbon dioxide source” refers to a reservoir, a pressurized cylinder, or tank containing carbon dioxide gas.
- The term “comprising” includes, but is not limited to, whatever follows the word “comprising.” Use of the term indicates the listed elements are required or mandatory but that other elements are optional and may be present.
- The terms “conditioning” or “to condition” refer to processes designed to allow safe and effective use of a component in dialysis.
- A “conditioning solution,” as used herein, is a solution containing bicarbonate ions for use in conditioning a zirconium oxide module.
- A “connector” and “for connection” describe the concept of forming a fluid connection between two components wherein fluid, gas, or mixture of both gas and fluid can flow from one component, through a connector or a component for connection, to another component. The connector provides for a fluid connection in its broadest sense and can include any type of tubing, fluid or gas passageway, or conduit between any one or more components of the invention. The connection can optionally be disconnected and then reconnected.
- The term “consisting of” includes and is limited to whatever follows the phrase “consisting of.” The phrase indicates the limited elements are required or mandatory and that no other elements may be present.
- The term “consisting essentially of” includes whatever follows the term “consisting essentially of” and additional elements, structures, acts or features that do not affect the basic operation of the apparatus, structure or method described.
- A “control system” can be a combination of components that act together to maintain a system to a desired set of performance specifications. The control system can use processors, memory and computer components configured to interoperate to maintain the desired performance specifications. The control system can also include fluid or gas control components, and solute control components as known within the art to maintain the performance specifications.
- The term “desired zirconium oxide effluent pH” refers to a preferred pH range for fluid exiting a zirconium oxide module during dialysis.
- The terms “determining” and “determine” refer to ascertaining a particular state or desired state of a system or variable(s).
- A “dialysate flow path” is a route in which a fluid will travel during dialysis.
- The term “disinfectant solution” refers to any solution capable of destroying or removing bacterial contaminants from a reusable sorbent module.
- The terms “disinfecting,” “disinfected,” or to “disinfect” refer to removing bacterial contaminants from a component or system.
- A “flow path” is one or more connectors or components through which fluid can travel.
- The term “fluid” can be any substance that has no fixed shape that yields easily to external pressure such as a gas or a liquid. Specifically, the fluid can be water containing any solutes at any concentration.
- The term “fluidly connectable,” “fluidly connected,” and “for fluid connection” refer to the ability to pass fluid or gas from one point to another point. The two points can be within or between any one or more of compartments, modules, systems, components, and rechargers, all of any type. The connection can optionally be disconnected and then reconnected.
- A “fluid connector,” “fluid connection,” and the like describe a connection between two components wherein fluid or gas can flow from one component, through a connector or a component for connection, to another component. The connector provides for a fluid connection in its broadest sense and can include any type of tubing, fluid or gas passageway, or conduit between any one or more components of the invention. The connection can optionally be disconnected and then reconnected.
- The terms “generating” or “to generate” refer to creating a fluid with a specified concentration, pH, temperature, and/or volume from one or more fluid sources.
- The term “mixing” or “to mix” generally refers to causing two or more fluids from any source to combine together. For example, “mixing” can include turbulent flow at a location in a fluid line or a junction. Another example of “mixing” can include receiving one or more fluids in a component configured to receive fluids from one or multiple sources and to mix the fluids together in the component. Yet another example of “mixing” includes one or more fluids used in dissolution of one or more solid components to be dissolved in one or more fluids.
- A “module inlet” is a connector through which a fluid, slurry, or aqueous solution can enter a sorbent module.
- A “module outlet” is a connector through which a fluid, slurry, or aqueous solution can exit a sorbent module.
- The term “pH sensor” refers to a device for measuring the pH or H+ concentration of a liquid in a vessel, container, or fluid line.
- The term “pressure sensor” refers to a device for measuring the pressure of a gas or liquid in a vessel, container, or fluid line.
- The term “pump” refers to any device that causes the movement of fluids or gases by applying suction or pressure.
- The terms “pumping,” “pumped,” or to “pump” refer to moving a fluid with a pump.
- “Recharging” refers to treating a sorbent material to restore the functional capacity of the sorbent material to put the sorbent material back into a condition for reuse or use in a new dialysis session. In some instances, the total mass, weight and/or amount of “rechargeable” sorbent materials remain the same. In some instances, the total mass, weight and/or amount of “rechargeable” sorbent materials change. Without being limited to any one theory of invention, the recharging process may involve exchanging ions bound to the sorbent material with different ions, which in some instances may increase or decrease the total mass of the system. However, the total amount of the sorbent material will in some instances be unchanged by the recharging process. Upon a sorbent material undergoing “recharging,” the sorbent material can then be said to be “recharged.”
- A “recharging flow path” is a path through which fluid can travel while recharging sorbent material in a reusable sorbent module.
- A “receiving compartment” is a space within a recharger or other apparatus into which a sorbent module to be recharged is placed.
- The term “saturated” refers to a solution containing the greatest amount of a solute under given operating conditions.
- The term “solid sodium bicarbonate” refers to sodium bicarbonate in the solid phase, and can include either granular, crystalline, or powdered forms, or combinations thereof, of the sodium bicarbonate.
- A “sorbent cartridge module” or “sorbent module” means a discreet component of a sorbent cartridge. Multiple sorbent cartridge modules can be fitted together to form a sorbent cartridge of two, three, or more sorbent cartridge modules. In some embodiments, a single sorbent cartridge module can contain all of the necessary materials for dialysis. In such cases, the sorbent cartridge module can be a “sorbent cartridge.”
- A sorbent “recharger” is an apparatus designed to recharge at least one sorbent material.
- A “static mixer” is a component configured to receive fluids from one or multiple sources and to mix the fluids together. The static mixer may include components that agitate the fluids to further mixing.
- “Zirconium oxide”, also known as hydrous zirconium oxide, is a sorbent material that removes anions from a fluid, exchanging the removed anions for different anions.
- A “zirconium oxide sorbent module” is a sorbent module containing zirconium oxide.
- “Zirconium phosphate” is a sorbent material that removes cations from a fluid, exchanging the removed cations for different cations.
- A “zirconium phosphate sorbent module” is a sorbent module containing zirconium phosphate.
- The invention is drawn to systems and methods for conditioning a zirconium oxide sorbent module after recharging for reuse in dialysis.
FIG. 1 illustrates a non-limiting embodiment of a recharger flow path for recharging and conditioning of a zirconiumoxide sorbent module 102. The zirconiumoxide sorbent module 102 can be placed in a receiving compartment of a recharger and fluidly connected to therecharging flow path 101 through zirconiumoxide module inlet 103 and zirconiumoxide module outlet 104 intoeffluent line 109. A base solution containing a strong base, such as sodium hydroxide, can be pumped through the zirconiumoxide sorbent module 102 frombase source 105 fluidly connected to rechargingflow path 101.Pump 107 provides a driving force for pumping the fluids through rechargingflow path 101. The hydroxide ions in the base solution will displace phosphate and other anions bound to the zirconium oxide during dialysis. After pumping base solution through the zirconiumoxide sorbent module 102, the zirconium oxide will be substantially saturated with hydroxide ions, and in a state that will consume total carbonate from solutions, including CO3 2−, HCO3 − and CO2 gas. The consumption of total carbonate by the zirconium oxide creates a basic dialysate having an unacceptable pH for therapy. To avoid consumption of total carbonate, the zirconium oxide must be conditioned. The conditioning process places the zirconiumoxide sorbent module 102 in an appropriate chemical state for reuse in dialysis. Conditioning of the zirconium oxide with sodium bicarbonate places the zirconium oxide in pH equilibrium with the bicarbonate conditioning solution. To condition the zirconium oxide in the zirconiumoxide sorbent module 102, bicarbonate solution at a predetermined desired zirconium oxide effluent pH is pumped through the zirconiumoxide sorbent module 102 frombicarbonate source 106 fluidly connected to rechargingflow path 101.Valve 108 controls the movement of fluid from thebase source 105 andbicarbonate source 106 through therecharging flow path 101. One of skill in the art will understand that additional or alternative fluid sources can be included for recharging and conditioning of the zirconiumoxide sorbent module 102. A disinfectant source (not shown) containing a disinfectant solution such as bleach, peracetic acid, citric acid, or any other disinfectant known in the art, can be included for disinfecting the zirconiumoxide sorbent module 102 prior to reuse. The zirconiumoxide sorbent module 102 can be disinfected with bleach, peracetic acid, citric acid, or any other disinfectant by pumping a disinfectant solution through the zirconiumoxide sorbent module 102 at the beginning of the recharging and conditioning process, after conditioning and recharging, or in parallel with any of the conditioning or recharging steps. The zirconiumoxide sorbent module 102 can be disinfected and recharged in parallel by using a combined base and bleach solution. Alternatively, the zirconiumoxide sorbent module 102 can be disinfected and conditioned in parallel by using a combined bicarbonate and bleach solution at the desired zirconium oxide effluent pH. A water source (not shown) can be included for rinsing or flushing the zirconiumoxide sorbent module 102 before or after disinfection or recharging or conditioning. - The conditioning solution is pumped through the zirconium
oxide sorbent module 102 for a sufficient length of time to ensure complete conditioning. The conditioning solution can be pumped through the zirconiumoxide sorbent module 102 for any length of time including between any of 5 and 30 minutes, 5 and 10 minutes, 5 and 8 minutes, 7 and 10 minutes, 8 and 12 minutes, 10 and 15 minutes, 10 and 30 minutes, 15 and 25 minutes, or 20 and 30 minutes. - During dialysis, the zirconium
oxide sorbent module 102 is used with zirconium phosphate and other sorbent materials for regeneration of dialysate. To simplify therapy and therapy modeling, equilibration of the zirconium oxide module with the zirconium phosphate is desired. The equilibration of zirconium phosphate and zirconium oxide means the pH of the zirconium oxide and zirconium phosphate effluents during therapy are the same. For example, if a desired zirconium phosphate effluent pH is determined to be 6.5, then the desired zirconium oxide effluent pH can also be 6.5 and the conditioning process can use a bicarbonate solution at a pH of 6.5 to place the zirconium phosphate and zirconium oxide sorbent modules in an equilibrium state. However, the zirconium oxide can be conditioned to any desired zirconium oxide effluent pH by using a bicarbonate solution at the desired zirconium oxide effluent pH. - The bicarbonate in
bicarbonate source 106 can include bicarbonate ions in solid and/or solution form. For example, a bicarbonate dry cartridge may be included inbicarbonate source 106. Water can be added to thebicarbonate source 106 to dissolve the bicarbonate in the dry cartridge, or flowed through the dry cartridge, generating a bicarbonate solution of known concentration for use in conditioning. Alternatively,bicarbonate source 106 can include a premade bicarbonate solution. - The concentration of the bicarbonate in
bicarbonate source 106 can be any concentration leading to a desired zirconium oxide effluent pH. In certain embodiments, the concentration of bicarbonate used in conditioning the zirconium oxide can be between 0.1 M and saturated, between 0.1 M and 1.0 M, between 0.5 M and 1.0 M, between 0.5 M and 2.0 M, between 1.0 M and saturated, or between 2.0 and saturated. The desired zirconium oxide effluent pH can be any pH, and in a preferred embodiment is between 5.0 and 7.5. In certain embodiments, the desired zirconium effluent pH can be between any of 5.0 and 6.0, between 5.0 and 6.5, between 5.5 and 6.5, between 5.5 and 7.0, between 6.0 and 7.5, or between 6.5 and 7.5. In certain embodiments, the conditioning solution can be heated to a specified temperature while conditioning the zirconium oxide. The conditioning solution can be heated to any temperature between 20 and 100° C., including between 20 and 35° C., between 20 and 50° C., between 40 and 60° C., between 40 and 80° C., between 50 and 75° C., or between 50 and 100° C. Approximately 4 mmoles of bicarbonate per gram of zirconium oxide is necessary for full conditioning of a zirconium oxide sorbent module with a phosphate capacity of about 0.8 mmoles phosphate/g of zirconium oxide. One of ordinary skill in the art will understand more bicarbonate will be necessary for a zirconium oxide module containing more zirconium oxide, or having a higher phosphate capacity. For example, the bicarbonate solution can be a 1M bicarbonate solution at a pH of 6.5, requiring 1.3 L of conditioning solution. At higher concentrations, less conditioning solution will be required. However, because significant carbon dioxide gas will be in equilibrium with the bicarbonate at a pH of around 6.5, a high pressure is required to create a stable 6.5 pH bicarbonate solution at high concentration. If the pressure is not high enough, degassing and release of carbon dioxide will occur. The concentration and volume of the bicarbonate conditioning solution used can be based on the desired zirconium oxide effluent pH and the pressure capabilities of the system. The conditioning solution used can be any volume, including between any of 0.5 and 20.0 L, 0.5 and 1.0 L, 0.75 and 1.25 L, 1.0 and 1.5 L, 1.0 and 5.0 L, 2.5 and 7.5 L, 5.0 and 15.0 L, 5.0 and 20.0 L, or 10.0 and 20.0 L. Although therecharging flow path 101 is illustrated as a flow path for both recharging and conditioning a zirconiumoxide sorbent module 102, one of skill in the art will understand that a separate conditioning apparatus can be constructed withoutbase source 105 solely for conditioning of the zirconiumoxide sorbent module 102. - The conditioning solution containing sodium bicarbonate at a desired zirconium oxide effluent pH can be provided in a
pre-mixed bicarbonate source 106 at the proper pH, as illustrated inFIG. 1 . Alternatively, the conditioning solution can be generated by the system.FIG. 2 illustrates a system for generating the conditioning solution. A zirconiumoxide sorbent module 202 can be placed in a receiving compartment of a recharger or separate conditioning apparatus and connect to flowpath 201 through zirconium oxidesorbent module inlet 203 and zirconium oxidesorbent module outlet 204 intoeffluent line 209. To generate the conditioning solution, sodium bicarbonate frombicarbonate source 205 can be mixed with an acid fromacid source 206.Pump 207 provides a driving force for pumping fluid through theflow path 201. The acid inacid source 206 can be any acid, including acetic acid, hydrochloric acid, or any other acid known in the art. The concentrations of bicarbonate inbicarbonate source 205 and acid inacid source 206 can be set to generate a conditioning fluid having a desired zirconium oxide effluent pH when mixed inflow path 201. A static mixer (not shown) can be included inflow path 201 to ensure mixing of the acid and bicarbonate. Alternatively, the acid and bicarbonate can be mixed through mixing of the fluid streams at the junction between the two lines. ApH sensor 208 ensures the pH of the mixed conditioning solution is within an acceptable range of the desired zirconium oxide effluent pH. Valves (not shown) can be included to control the movement of fluid from thebicarbonate source 205 andacid source 206, allowing a customizable conditioning solution having a variable pH controlled by the relative amounts of bicarbonate and acid used. One of skill in the art will understand a base source (not shown) can be included in theflow path 201 ofFIG. 2 for recharging the zirconiumoxide sorbent module 202 prior to conditioning in a single system. Alternatively, a separate recharger can recharge the zirconiumoxide sorbent module 202, and conditioning carried out with a different apparatus. -
FIG. 3 illustrates an alternative method of generating a conditioning solution using carbon dioxide gas fromcarbon dioxide source 306. A zirconiumoxide sorbent module 302 can be placed in a receiving compartment of a recharger or conditioning apparatus and connect to flowpath 301 through zirconiumoxide module inlet 303 and zirconiumoxide module outlet 304 intoeffluent line 309.Pump 307 provides a driving force for moving fluid through theflow path 301. Abicarbonate source 305 fluidly connected to flowpath 301 can contain a bicarbonate solution at a higher pH. Carbon dioxide gas fromcarbon dioxide source 306 can be metered into thebicarbonate source 305 through a fluid connector to create a bicarbonate solution having a desired zirconium oxide effluent pH.Pressure regulator 308 controls the flow of carbon dioxide gas to thebicarbonate source 305, allowing control over the pH of the fluid after mixing. A pressure sensor (not shown) ensures the correct pressure of carbon dioxide is delivered to thebicarbonate source 305. A pH sensor (not shown) can ensure the pH of the generated solution is at the desired zirconium oxide effluent pH. One of skill in the art will understand a base source (not shown) can be included in theflow path 301 ofFIG. 3 for recharging the zirconiumoxide sorbent module 302 prior to conditioning in a single system. Alternatively, a separate recharger can recharge the zirconiumoxide sorbent module 302, and conditioning carried out with a different apparatus. -
FIG. 4 illustrates aflow path 401 with a zirconiumphosphate sorbent module 406 for generating the conditioning solution. The zirconiumoxide sorbent module 402 can be placed in a receiving compartment of a recharger or conditioning apparatus and connect to theflow path 401 through zirconiumoxide module inlet 403 and zirconiumoxide module outlet 404 intoeffluent line 410.Pump 407 provides a driving force for pumping fluid through theflow path 401.Bicarbonate source 405, fluidly connected to flowpath 401, can contain bicarbonate at any pH. A second receiving compartment can receive a zirconiumphosphate sorbent module 406. The bicarbonate solution passes through zirconiumphosphate sorbent module 406, connected by a fluid connector to theflow path 401 through zirconiumphosphate module inlet 409 and zirconiumphosphate module outlet 408. The bicarbonate conditioning solution will equilibrate with the zirconiumphosphate sorbent module 406, generating a bicarbonate solution with a pH dependent upon the relative amounts of hydrogen and sodium loaded onto the zirconiumphosphate sorbent module 406. As such, if the zirconiumphosphate sorbent module 406 is the same zirconium phosphate sorbent module used with the zirconiumoxide sorbent module 402 in dialysis, or is loaded with hydrogen and sodium ions in the same ratio as the zirconium phosphate sorbent module used in dialysis, then the pH of the conditioning solution exiting zirconiumphosphate sorbent module 406 will be at the desired equilibrium pH. One of skill in the art will understand a base source (not shown) can be included in theflow path 401 ofFIG. 4 for recharging the zirconiumoxide sorbent module 402 prior to conditioning in a single system. Alternatively, a separate recharger can recharge the zirconiumoxide sorbent module 402, and conditioning carried out with a different apparatus. The zirconiumphosphate sorbent module 406 illustrated inFIG. 4 can be a dedicated zirconium phosphate sorbent module, or a zirconium phosphate sorbent module that will be removed from theflow path 401 and used in subsequent dialysis. A dedicated zirconium phosphate sorbent module can generate the conditioning solution through multiple cycles before being recharged or replaced. Approximately 150 g of zirconium phosphate is necessary for conditioning of a zirconium oxide module. A larger zirconium phosphate sorbent module can be used for multiple conditioning cycles without recharging. For example, a zirconium phosphate sorbent module containing 1,500 g of zirconium phosphate can be used for approximately 10 conditioning cycles before being replaced or recharged. Any size zirconium phosphate sorbent module can be used for conditioning the zirconium oxide sorbent modules. -
FIG. 5 illustrates arecharging flow path 500 for recharging both zirconium phosphate and zirconium oxide, with the recharged zirconiumphosphate sorbent module 506 used to generate the conditioning solution. The zirconiumoxide sorbent module 502 can be placed in a receiving compartment of the recharger and connect to a zirconium oxiderecharging flow path 501 through zirconiumoxide module inlet 503 and zirconiumoxide module outlet 504 intoeffluent line 520.Pump 511 provides a driving force for moving fluid through the zirconium oxiderecharging flow path 501. Base solution frombase source 505 can be pumped throughvalve 512 and through zirconiumoxide sorbent module 502 to recharge the zirconium oxide. The recharger can also have a second receiving compartment for receiving a zirconiumphosphate sorbent module 506, which can connect to zirconium phosphaterecharging flow path 519 through zirconiumphosphate module inlet 507 and zirconiumphosphate module outlet 508. The zirconiumphosphate sorbent module 506 is recharged by pumping a brine solution frombrine source 509 throughvalve 514 and zirconiumphosphate sorbent module 506. The brine solution can contain acids, bases, salts, or combinations thereof. The hydrogen and sodium ions in the brine solution displace potassium, calcium, magnesium, ammonium, and other cations adsorbed by the zirconium phosphate during dialysis. Pump 513 provides a driving force for moving fluid through zirconium phosphaterecharging flow path 519. The effluent exiting zirconium phosphatesorbent module outlet 508 can pass throughvalve 515 to drain line 517 to wastereservoir 516 or a drain (not shown). The basic effluent exiting zirconiumoxide sorbent module 502 can be pumped to thesame waste reservoir 516, drain (not shown) or collected separately for in a separate waste reservoir (not shown) for later disposal. - After recharging of both the zirconium
oxide sorbent module 502 and zirconiumphosphate sorbent module 506, the zirconiumoxide sorbent module 502 can be conditioned. Bicarbonate solution from bicarbonate source 510 can be pumped through the zirconiumphosphate sorbent module 506, generating a bicarbonate solution at the desired zirconium oxide effluent pH.Valve 515 can be switched to direct the bicarbonate solution intofluid connector 518 and tovalve 512 in the zirconium oxiderecharging flow path 501. The bicarbonate solution is pumped fromvalve 512 through the zirconiumoxide sorbent module 502 to condition the zirconiumoxide sorbent module 502. -
FIGS. 1-5 illustrate various methods of conditioning a recharged zirconium oxide sorbent module in either a recharger or a separate conditioning system. The recharged zirconium oxide sorbent module can also be conditioned in a dialysate flow path 601 during priming of the system, as illustrated inFIG. 6 .FIG. 6 is a simplified diagram of a dialysate flow path 601. During treatment, dialysate is pumped through the dialysate flow path 601 anddialyzer 605.Pump 604 provides the driving force for pumping fluid through the dialysate flow path 601. At the same time blood is pumped through thedialyzer 605 on the opposite side of asemipermeable membrane 606. Waste products in the blood of the patient cross thesemipermeable membrane 606 and enter the dialysate in thedialyzer 605. The waste products are removed from the dialysate by asorbent cartridge 609, which includes a zirconiumphosphate sorbent module 603 and a zirconiumoxide sorbent module 602. One of skill in the art will understand additional materials can be included in thesorbent cartridge 609, such as activated carbon, urease, and alumina (not shown). To prime the system and thesorbent cartridge 609, a solution containing sodium bicarbonate is pumped through the dialysate flow path 601, thedialyzer 605, and thesorbent cartridge 609. In certain embodiments, the solution can also contain sodium chloride. Alternatively, the method can use a sodium bicarbonate solution followed by a sodium chloride solution, or a sodium chloride solution followed by a sodium bicarbonate solution. Water from a water source (not shown), sodium chloride from a sodium chloride source (not shown) are added to the dialysate flow path 601, and sodium bicarbonate frombicarbonate source 607 is added to the dialysate flow path 601 by pump 608. The resulting priming solution is pumped through the dialysate flow path 601 to prime the system. The priming solution, containing bicarbonate, is pumped through zirconiumphosphate sorbent module 603, generating a bicarbonate solution at the desired zirconium oxide effluent pH, and then through zirconiumoxide sorbent module 602, conditioning the zirconiumoxide sorbent module 602. After addition of bicarbonate the priming solution can be recirculated within dialysate flow path 601 in order to maximize the utilization of bicarbonate. In certain embodiments, one pass of fluid through the dialysate flow path 601 can be conducted with adding bicarbonate, and a second pass of the fluid can be done without adding additional bicarbonate. - Conditioning the zirconium
oxide sorbent module 602 during priming requires additional bicarbonate in the dialysis system and lengthens the time necessary for priming. The additional amount of bicarbonate solution needed for conditioning during priming can be about 80 to 120 g of sodium bicarbonate. Conditioning the zirconiumoxide sorbent module 602 during priming also adds between 5-15 minutes to the priming process. Conditioning the zirconiumoxide sorbent module 602 in a recharger or a separate conditioning system allows a smaller bicarbonate source for therapy and a faster priming process. In any embodiment, the zirconiumoxide sorbent module 602 can be conditioned partly in a recharger or conditioning system, and partly during priming, reducing the additional bicarbonate necessary during priming of the system. After conditioning, excess sodium bicarbonate can be rinsed intodrain line 609 bypump 610 or used in subsequent priming steps. Thedrain line 609 can be fluidly connected to adrain reservoir 611, or alternatively, directly to a drain (not shown). -
FIG. 7 is an alternative simplified diagram of adialysate flow path 701. During treatment, dialysate is pumped through thedialysate flow path 701 anddialyzer 705. Pump 704 provides the driving force for pumping fluid through thedialysate flow path 701. At the same time blood is pumped through thedialyzer 705 on the opposite side of a semipermeable membrane 706. Waste products in the blood of the patient can cross the semipermeable membrane 706 and enter the dialysate in thedialyzer 705. The waste products are removed from the dialysate by asorbent cartridge 709, which includes a zirconiumphosphate sorbent module 710, a zirconium oxide sorbent module 702, and an additional sorbent module 703. The additional sorbent module 703 can contain a solid sodium bicarbonate or powder, which can be used to generate the conditioning solution in thedialysate flow path 701. One of skill in the art will understand that additional materials can be included in thesorbent cartridge 709, such as activated carbon, urease, and alumina (not shown). In certain embodiments, activated carbon, urease, and alumina can be contained in sorbent module 703 with the bicarbonate. Alternatively, the solid sodium bicarbonate can be placed in thesame sorbent module 710 as the zirconium phosphate. To prime the system and thesorbent cartridge 709, a solution containing sodium chloride is pumped through thedialysate flow path 701, thedialyzer 705, and thesorbent cartridge 709. Water from a water source (not shown) and optionally sodium chloride from a sodium chloride source (not shown) can be added to thedialysate flow path 701. The fluid, while flowing through sorbent module 703, can dissolve the sodium bicarbonate within sorbent module 703 to generate a priming and conditioning solution containing sodium bicarbonate. In certain embodiments, the conditioning solution can also contain sodium chloride. Alternatively, the method can generate a sodium bicarbonate solution, followed by a sodium chloride solution. By using a solid sodium bicarbonate in the sorbent module 703, the size requirements for bicarbonate source 707 are reduced, and the priming and conditioning time is reduced. The resulting priming solution is pumped through thedialysate flow path 701 to prime the system. The priming solution, containing bicarbonate dissolved by fluid passing through sorbent module 703, is pumped through zirconiumphosphate sorbent module 710, generating a bicarbonate solution at the desired zirconium oxide effluent pH, and then through zirconium oxide sorbent module 702, conditioning the zirconium oxide sorbent module 702. - Conditioning the zirconium oxide sorbent module 702 with a conditioning solution formed by dissolving solid sodium bicarbonate in sorbent module 703 requires a quantity of sodium bicarbonate to be initially present in the sorbent module 703. The amount of bicarbonate present in sorbent module 703 can be any amount sufficient to fully condition the zirconium oxide sorbent module 702. In certain embodiments, the amount of sodium bicarbonate placed in sorbent module 703 can be between 40 and 130 grams, between 40 and 60 grams, between 50 and 100 grams, between 50 and 130 grams, between 75 and 100 grams, or between 80 and 130 grams. The necessary amount of sodium bicarbonate can vary depending on the size of zirconium oxide sorbent module 702. In certain embodiments, an excess of sodium bicarbonate beyond that necessary for conditioning zirconium oxide sorbent module 702 can be placed in sorbent module 703. After conditioning, the excess bicarbonate can be rinsed from the
dialysate flow path 701 intodrain line 711 bypump 712 or used in subsequent priming steps. After generation of the bicarbonate solution the bicarbonate solution can be recirculated withindialysate flow path 701 in order to maximize the utilization of bicarbonate during priming. Thedrain line 711 can be fluidly connected to adrain reservoir 713, or alternatively, directly to a drain (not shown). - As described, the pH of the conditioning solution can be the same pH as the effluent from the zirconium phosphate sorbent module subsequently used in dialysis.
-
FIG. 8 is a flow chart illustrating the steps of recharging and conditioning a zirconium oxide sorbent module to the correct pH. Instep 801, a desired zirconium oxide effluent pH can be determined. Instep 802, the zirconium oxide sorbent module is recharged with a strong base. Instep 803, the conditioning solution is generated. Any of the described methods for generating the conditioning solution can be used instep 803, including mixing a bicarbonate solution with acid, mixing a bicarbonate solution with carbon dioxide, pumping a bicarbonate solution through a dedicated or non-dedicated zirconium phosphate sorbent module either in a recharger, a conditioning system, or a dialysate flow path, or pumping water through a sorbent module containing solid sodium bicarbonate in a dialysate flow path. In step 804, the conditioning solution is pumped through the zirconium oxide sorbent module. Instep 805, the zirconium oxide sorbent module is reused in dialysis. -
FIG. 9 illustrates a non-limiting embodiment of a recharger for recharging and conditioning zirconium oxide in a zirconium oxide module. Therecharger 901 includes a zirconiumoxide receiving compartment 904 for receiving a zirconiumoxide sorbent module 905. Therecharger 901 can also have a zirconiumphosphate receiving compartment 902 for receiving a zirconiumphosphate sorbent module 903. The zirconiumphosphate sorbent module 903 can be a dedicated zirconium phosphate sorbent module, or a zirconium phosphate sorbent module that will be used in a subsequent dialysis session. The conditioning solution can be pumped through the zirconiumphosphate sorbent module 903 and then into the zirconiumoxide sorbent module 905 for conditioning. Alternatively, the conditioning solution can be generated or stored separately, and need not pass through the zirconiumphosphate sorbent module 903.Door 907 controls access to the receivingcompartments recharger 901 for recharging and conditioning of the zirconiumoxide sorbent module 905. Fluid connections (not shown inFIG. 9 ) connect to the top and bottom of thesorbent modules reusable sorbent modules phosphate sorbent module 903. Auser interface 906 is provided to start or control the recharging and conditioning processes by the user. Theuser interface 906 also provides the status of the recharging and conditioning processes to the user, such as the times of completion of each step, or a time until the processes are complete.User interface 906 also provides alert messages if any problems are detected during recharging, such as leaks, occlusions, pump failures, or mismatched chemicals.User interface 906 also allows the user to input the desired zirconium oxide effluent pH to control the conditioning process. - Although shown with receiving
compartments FIG. 9 , therecharger 901 can be similarly constructed with solely a zirconium oxide receiving compartment. As described, the conditioning solution can be generated separately, and need not pass through a zirconium phosphate sorbent module. The rechargers can have any number of receiving compartments for any combination of zirconium oxide and zirconium phosphate sorbent modules, including 1, 2, 3, 4, 5, 6, 7 or more receiving compartments for recharging and conditioning of any number of zirconium oxide modules. - As illustrated in
FIG. 10 , multiple rechargers can be chained together and connected to a single set of fluid sources for sharing of infrastructure. Afirst recharger 1001 having a zirconiumphosphate receiving compartment 1003 and zirconiumoxide receiving compartment 1002 is fluidly connected towater source 1007,bicarbonate source 1008,disinfectant source 1009, andbase source 1010. The zirconium phosphate module used can be a dedicated zirconium phosphate sorbent module, or a zirconium phosphate sorbent module that will be used in subsequent dialysis. For recharging both zirconium phosphate and zirconium oxide in the recharger, a brine source (not shown) can be included for zirconium phosphate recharging. Asecond recharger 1004 having a zirconiumoxide receiving compartment 1005 and zirconiumphosphate receiving compartment 1006 is also fluidly connected to thesame water source 1007,bicarbonate source 1008,disinfectant source 1009, andbase source 1010. Any number of rechargers can be connected to a common set of fluid sources, including 2, 3, 4, 5, 6 or more rechargers, each fluidly connected to a single set of fluid sources and a single set of waste reservoirs. Connecting multiple rechargers to a single set of fluid sources saves space and materials and simplifies recharging multiple sets of reusable modules in a clinic or hospital setting. Each of the rechargers may include a separate drain line and/or separate waste reservoirs, or each recharger may be fluidly connected to a common drain line. The drain line can also be fluidly connected to any one of a drain, a common reservoir, or combinations thereof. As described, the rechargers can alternatively only have zirconium oxide receiving compartments for recharging and conditioning solely of zirconium oxide. - One skilled in the art will understand that various combinations and/or modifications and variations can be made in the described systems and methods depending upon the specific needs for operation. Moreover features illustrated or described as being part of an aspect of the invention may be used in the aspect of the invention, either alone or in combination, or follow a preferred arrangement of one or more of the described elements.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/197,665 US11642654B2 (en) | 2016-11-29 | 2021-03-10 | Zirconium oxide module conditioning |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662427806P | 2016-11-29 | 2016-11-29 | |
US15/798,233 US10981148B2 (en) | 2016-11-29 | 2017-10-30 | Zirconium oxide module conditioning |
US17/197,665 US11642654B2 (en) | 2016-11-29 | 2021-03-10 | Zirconium oxide module conditioning |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/798,233 Continuation US10981148B2 (en) | 2016-11-29 | 2017-10-30 | Zirconium oxide module conditioning |
Publications (2)
Publication Number | Publication Date |
---|---|
US20210187481A1 true US20210187481A1 (en) | 2021-06-24 |
US11642654B2 US11642654B2 (en) | 2023-05-09 |
Family
ID=60673086
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/798,233 Active 2039-08-14 US10981148B2 (en) | 2016-11-29 | 2017-10-30 | Zirconium oxide module conditioning |
US17/197,665 Active 2038-04-05 US11642654B2 (en) | 2016-11-29 | 2021-03-10 | Zirconium oxide module conditioning |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/798,233 Active 2039-08-14 US10981148B2 (en) | 2016-11-29 | 2017-10-30 | Zirconium oxide module conditioning |
Country Status (4)
Country | Link |
---|---|
US (2) | US10981148B2 (en) |
EP (1) | EP3326668B1 (en) |
CN (1) | CN108159733B (en) |
CA (1) | CA2986121A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10981148B2 (en) * | 2016-11-29 | 2021-04-20 | Medtronic, Inc. | Zirconium oxide module conditioning |
US20200054807A1 (en) * | 2018-08-14 | 2020-02-20 | Medtronic, Inc. | Precision dialysis therapy based on sorbent effluent analysis |
US11090421B2 (en) * | 2018-11-28 | 2021-08-17 | Baxter International Inc. | Systems and methods for batch sorbent material reuse |
US11331597B2 (en) | 2019-08-05 | 2022-05-17 | Fresenius Medical Care Holdings, Inc. | Cation exchange materials for dialysis systems |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5685835A (en) * | 1995-06-07 | 1997-11-11 | Cobe Laboratories, Inc. | Technique for using a dialysis machine to disinfect a blood tubing set |
US20020147109A1 (en) * | 1999-07-11 | 2002-10-10 | Solmecs (Israel) Ltd. | Sorbent composition |
US20040127648A1 (en) * | 2002-12-31 | 2004-07-01 | Ciphergen Biosystems, Inc. | Sorbent and method for the separation of plasmid DNA |
US10981148B2 (en) * | 2016-11-29 | 2021-04-20 | Medtronic, Inc. | Zirconium oxide module conditioning |
Family Cites Families (410)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1617288A (en) | 1925-03-16 | 1927-02-08 | Zeolite Engineering Co | Method of and apparatus for reconditioning zeolite water softeners |
US2703313A (en) | 1950-01-09 | 1955-03-01 | Aerojet General Co | Cation exchange apparatus |
GB1189458A (en) | 1967-09-27 | 1970-04-29 | Nat Res Dev | Improvements in or relating to dialysers |
US3669878A (en) | 1968-12-02 | 1972-06-13 | Health Education And Welfare U | Treatment of dialysate solution for removal of urea |
FR2036413A5 (en) | 1969-03-13 | 1970-12-24 | Thomson Csf | |
US3669880A (en) | 1969-06-30 | 1972-06-13 | Cci Aerospace Corp | Recirculation dialysate system for use with an artificial kidney machine |
US3776819A (en) | 1969-12-22 | 1973-12-04 | Monsanto Co | Urea determination and electrode therefor |
US3617558A (en) | 1970-11-02 | 1971-11-02 | Illinois Water Treatment Co | Layered ion exchange process |
DE2239254C2 (en) | 1970-12-30 | 1983-08-04 | Organon Teknika Corp., Oklahoma City, Okla. | "Column for regenerating a circulating dialysate solution and using this column". |
US3850835A (en) | 1971-11-08 | 1974-11-26 | Cci Life Systems Inc | Method of making granular zirconium hydrous oxide ion exchangers, such as zirconium phosphate and hydrous zirconium oxide, particularly for column use |
US3884808A (en) | 1973-06-20 | 1975-05-20 | Res Dev Systems Inc | Wearable, self-regenerating dialysis appliance |
SE373752B (en) | 1973-07-05 | 1975-02-17 | V H Hyden | |
US4192748A (en) | 1973-07-05 | 1980-03-11 | Hyden Viktor H | Dialysis apparatus with selective chemical activity |
US3840835A (en) | 1973-09-04 | 1974-10-08 | Chase Shawmut Co | Electric current-limiting low voltage fuse |
US3902490A (en) | 1974-03-27 | 1975-09-02 | Univ Utah | Portable artificial kidney system |
JPS5155193A (en) | 1974-11-07 | 1976-05-14 | Kanebo Ltd | |
JPS51131393A (en) | 1975-05-09 | 1976-11-15 | Hitachi Ltd | High pressure choromatography and its device |
US4073725A (en) | 1975-05-09 | 1978-02-14 | Hitachi, Ltd. | Method and apparatus for liquid chromatography under elevated pressure |
US4060485A (en) | 1975-06-09 | 1977-11-29 | I T L Technology, Inc. | Dialysis apparatus |
US4142845A (en) | 1976-02-20 | 1979-03-06 | Lepp William A | Dialysis pump system having over-center cam tracks to lock rollers against tubing |
US4094775A (en) | 1977-02-28 | 1978-06-13 | California Institute Of Technology | Dialysis system |
US4581141A (en) | 1978-02-27 | 1986-04-08 | Purdue Research Foundation | Dialysis material and method for removing uremic substances |
IT1174707B (en) | 1978-05-03 | 1987-07-01 | Bonomini Vittorio | PORTABLE ARTIFICIAL KIDNEY FOR DIALYSIS |
US4209392A (en) | 1978-05-15 | 1980-06-24 | Wallace Richard A | Portable hepatic-assist method and apparatus for same |
US4206054A (en) | 1978-10-27 | 1980-06-03 | Leon Moore | Pyramidic aquarium filter-aerator |
US4376707A (en) | 1979-05-21 | 1983-03-15 | Gambro Dialysatoren G.M.B.H. & Co. K.G. | Process for the removal of urea from blood wash fluids and blood |
US4556063A (en) | 1980-10-07 | 1985-12-03 | Medtronic, Inc. | Telemetry system for a medical device |
US4374382A (en) | 1981-01-16 | 1983-02-15 | Medtronic, Inc. | Marker channel telemetry system for a medical device |
DE3110128A1 (en) | 1981-03-16 | 1982-09-23 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München | Process and apparatus for the detoxication and regeneration of blood, blood constituents and solutions resulting from the purification of blood, as well as kit for carrying out the process |
US4371385A (en) | 1981-04-28 | 1983-02-01 | Cobe Laboratories, Inc. | Deaerating liquid |
US4381999A (en) | 1981-04-28 | 1983-05-03 | Cobe Laboratories, Inc. | Automatic ultrafiltration control system |
US4750494A (en) | 1981-05-12 | 1988-06-14 | Medtronic, Inc. | Automatic implantable fibrillation preventer |
US4612122A (en) | 1981-06-29 | 1986-09-16 | Clara Ambrus | Removing heavy metal ions from blood |
US4650587A (en) | 1982-09-09 | 1987-03-17 | Akzona Incorporated | Ammonia scavenger |
US4460555A (en) | 1983-08-25 | 1984-07-17 | Organon Teknika Corporation | Ammonia scavenger |
US4678408A (en) | 1984-01-06 | 1987-07-07 | Pacesetter Infusion, Ltd. | Solenoid drive apparatus for an external infusion pump |
US4685903A (en) | 1984-01-06 | 1987-08-11 | Pacesetter Infusion, Ltd. | External infusion pump apparatus |
US4562751A (en) | 1984-01-06 | 1986-01-07 | Nason Clyde K | Solenoid drive apparatus for an external infusion pump |
US4765907A (en) | 1984-03-28 | 1988-08-23 | Research Development Systems, Inc. | Wearable, continuously internally operable and externally regenerable dialysis device |
US4661246A (en) | 1984-10-01 | 1987-04-28 | Ash Medical Systems, Inc. | Dialysis instrument with dialysate side pump for moving body fluids |
FR2574664B1 (en) | 1984-12-14 | 1987-03-06 | Issautier Gerald | HEMODIALYSIS DEVICE FOR AUTOMATICALLY CONTROLLING WEIGHT LOSS |
JPS61164562A (en) | 1985-01-16 | 1986-07-25 | 鐘淵化学工業株式会社 | Apparatus and method for treatment of body fluid component |
IT1191613B (en) | 1985-05-15 | 1988-03-23 | Eniricerche Spa | ZIRCONIUM PHOSPHATE AND ITS PREPARATION METHOD |
US4687582A (en) | 1985-12-23 | 1987-08-18 | Dixon Walter O | Method and apparatus for operating and regenerating ion exchangers |
DE3634763A1 (en) | 1986-10-11 | 1988-04-28 | Josef Magasi | DEVICE AND METHOD FOR CLEANING BLOOD |
DE3785147T2 (en) | 1986-11-07 | 1996-09-19 | Asahi Chemical Ind | Regenerated cellulose membrane and process for its manufacture. |
US4828693A (en) | 1987-09-22 | 1989-05-09 | Baxter Travenol Laboratories, Inc. | Water pressure regulator for hemodialysis apparatus |
GB8722854D0 (en) | 1987-09-29 | 1987-11-04 | Hardy S M | Implantable artificial kidney |
CA1327838C (en) | 1988-06-13 | 1994-03-15 | Fred Zacouto | Implantable device to prevent blood clotting disorders |
DE3912405C1 (en) | 1989-04-15 | 1990-10-31 | B. Braun Melsungen Ag, 3508 Melsungen, De | |
US5032615A (en) | 1989-10-31 | 1991-07-16 | The Regents Of The University Of California | Continuous hemodialysis using citrate |
US5477864A (en) | 1989-12-21 | 1995-12-26 | Smith & Nephew Richards, Inc. | Cardiovascular guidewire of enhanced biocompatibility |
US5127404A (en) | 1990-01-22 | 1992-07-07 | Medtronic, Inc. | Telemetry format for implanted medical device |
US5080653A (en) | 1990-04-16 | 1992-01-14 | Pacesetter Infusion, Ltd. | Infusion pump with dual position syringe locator |
US5097122A (en) | 1990-04-16 | 1992-03-17 | Pacesetter Infusion, Ltd. | Medication infusion system having optical motion sensor to detect drive mechanism malfunction |
JPH0490963A (en) | 1990-08-06 | 1992-03-24 | Toshiba Corp | Steering truck |
JP2981573B2 (en) | 1990-12-12 | 1999-11-22 | 富田製薬株式会社 | Phosphate ion adsorbent |
US5230702A (en) | 1991-01-16 | 1993-07-27 | Paradigm Biotechnologies Partnership | Hemodialysis method |
US5486286A (en) | 1991-04-19 | 1996-01-23 | Althin Medical, Inc. | Apparatus for performing a self-test of kidney dialysis membrane |
FR2680976B1 (en) | 1991-09-10 | 1998-12-31 | Hospal Ind | ARTIFICIAL KIDNEY PROVIDED WITH BLOOD CHARACTERISTIC MEANS OF DETERMINATION AND CORRESPONDING DETERMINATION METHOD. |
JPH0599464A (en) | 1991-10-08 | 1993-04-20 | Nec Corp | Air shower device |
US5192132A (en) | 1991-12-12 | 1993-03-09 | Mobil Oil Corporation | Temperature monitoring of a fixed-bed catalytic reactor |
FR2687307B1 (en) | 1992-02-14 | 1999-06-04 | Lascombes Jean Jacques | DEVICE FOR THE PREPARATION OF A SOLUTION FOR MEDICAL USE. |
FR2693110B1 (en) | 1992-07-06 | 1994-08-19 | Hospal Ind | Method for verifying the operation of sensors located on a dialysis liquid circuit and device using it. |
EP0616540B1 (en) | 1992-10-13 | 1998-08-26 | Baxter International Inc. | Hemodialysis monitoring system for hemodialysis machines |
EP0616689B1 (en) | 1992-10-13 | 1999-04-14 | Baxter International Inc. | Fluid sampling module |
US5849179A (en) | 1992-10-13 | 1998-12-15 | Baxter International Inc. | Automatic apparatus for obtaining equilibration samples of dialysate |
US5284470A (en) | 1992-11-02 | 1994-02-08 | Beltz Alex D | Wearable, portable, light-weight artificial kidney |
US5441049A (en) | 1992-12-28 | 1995-08-15 | Automata Medical Instrumentation, Inc. | Conductivity meter |
US5445610A (en) | 1993-01-15 | 1995-08-29 | University Of Cincinnati | Portable peritoneal dialysis cycler |
IT1260614B (en) | 1993-03-01 | 1996-04-22 | Sorin Biomedica Spa | PROCEDURE FOR MEASURING THE CONCENTRATION OF A SUBSTANCE IN A FLUID, ITS SYSTEM AND USE |
US5302288A (en) | 1993-03-19 | 1994-04-12 | Zimpro Environmental, Inc. | Treatment of highly colored wastewaters |
DE4321927C2 (en) | 1993-07-01 | 1998-07-09 | Sartorius Gmbh | Filter unit with degassing device |
US5308315A (en) | 1993-07-27 | 1994-05-03 | Raja N. Khuri | Method for determining the adequacy of dialysis |
US5685988A (en) | 1993-09-15 | 1997-11-11 | Malchesky; Paul | Dialysis process and system |
US5507723A (en) | 1994-05-24 | 1996-04-16 | Baxter International, Inc. | Method and system for optimizing dialysis clearance |
BR9508456A (en) | 1994-07-29 | 1997-12-23 | Gambro Ab | Process and device for measuring the concentration of urea or a similar substance in a composite solution |
US6572769B2 (en) | 1994-09-26 | 2003-06-03 | Rajan G. Rajan | Water treatment apparatus |
US5591344A (en) | 1995-02-13 | 1997-01-07 | Aksys, Ltd. | Hot water disinfection of dialysis machines, including the extracorporeal circuit thereof |
SE504633C2 (en) | 1995-07-03 | 1997-03-24 | Althin Madical Ab | Device for dialysis machine |
IT1276468B1 (en) | 1995-07-04 | 1997-10-31 | Hospal Dasco Spa | AUTOMATIC DIALYSIS METHOD AND EQUIPMENT |
US5944684A (en) | 1995-08-31 | 1999-08-31 | The Regents Of The University Of California | Wearable peritoneum-based system for continuous renal function replacement and other biomedical applications |
US5938634A (en) | 1995-09-08 | 1999-08-17 | Baxter International Inc. | Peritoneal dialysis system with variable pressure drive |
US6363279B1 (en) | 1996-01-08 | 2002-03-26 | Impulse Dynamics N.V. | Electrical muscle controller |
US5683432A (en) | 1996-01-11 | 1997-11-04 | Medtronic, Inc. | Adaptive, performance-optimizing communication system for communicating with an implanted medical device |
US20090012864A1 (en) | 2007-07-02 | 2009-01-08 | Goldberg Sheldon F | Compensation model for network services |
US5770086A (en) | 1996-01-25 | 1998-06-23 | Eureka| Science Corp. | Methods and apparatus using hydrogels |
EP0921722A1 (en) | 1996-06-24 | 1999-06-16 | Board Of Regents, The University Of Texas System | Automated closed recirculating aquaculture filtration system |
US6048732A (en) | 1996-10-16 | 2000-04-11 | Board Of Regents, The University Of Texas System | Receptor and method for citrate determination |
IT1288767B1 (en) | 1996-10-18 | 1998-09-24 | Hospal Dasco Spa | METHOD OF DETERMINING THE VALUE OF THE RECIRCULATION OF A SUSPENSION SUBJECT TO TREATMENT. |
US5858186A (en) | 1996-12-20 | 1999-01-12 | The Regents Of The University Of California | Urea biosensor for hemodialysis monitoring |
US20010009756A1 (en) | 1998-01-06 | 2001-07-26 | Derek Hei | Flow devices for the reduction of compounds from biological compositions and methods of use |
US5931801A (en) | 1997-01-21 | 1999-08-03 | Vasca, Inc. | Valve port assembly with interlock |
US6852090B2 (en) | 1997-02-14 | 2005-02-08 | Nxstage Medical, Inc. | Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge |
SE513034C2 (en) | 1997-06-02 | 2000-06-19 | Gambro Lundia Ab | Calculation of dialysis efficiency, especially by monitoring urea concentration |
ES2303347T3 (en) | 1997-08-13 | 2008-08-01 | Fresenius Medical Care Deutschland Gmbh | DEVICE FOR THE TREATMENT OF BLOOD WITH A DEVICE FOR THE DETERMINATION OF PARAMETERS OF HEMODIALISIS, AS WELL AS PROCEDURE FOR DETERMINATION. |
SE9703600D0 (en) | 1997-10-02 | 1997-10-02 | Pacesetter Ab | Heart stimulator |
US6390969B1 (en) | 1997-10-09 | 2002-05-21 | Orqis Medical Corporation | Implantable heart assist system and method of applying same |
US6088608A (en) | 1997-10-20 | 2000-07-11 | Alfred E. Mann Foundation | Electrochemical sensor and integrity tests therefor |
SE9703958D0 (en) | 1997-10-29 | 1997-10-29 | Pacesetter Ab | Method and device for determination of concentration |
US6648845B1 (en) | 1998-01-07 | 2003-11-18 | Fresenius Medical Care North America | Method and apparatus for determining hemodialysis parameters |
SE520638C2 (en) | 1998-01-21 | 2003-08-05 | Gambro Lundia Ab | Safety device for dialysis machine |
SE9800407D0 (en) | 1998-02-12 | 1998-02-12 | Pacesetter Ab | Heart stimulator |
US6197197B1 (en) | 1998-04-23 | 2001-03-06 | Dialysis Systems, Inc. | Method for fluid delivery in a dialysis clinic |
US6058331A (en) | 1998-04-27 | 2000-05-02 | Medtronic, Inc. | Apparatus and method for treating peripheral vascular disease and organ ischemia by electrical stimulation with closed loop feedback control |
US6358422B1 (en) | 1998-05-14 | 2002-03-19 | Amcol International Corporation | Method and apparatus for removing oil from water including monitoring of absorbent saturation |
SE525639C2 (en) | 1998-06-04 | 2005-03-22 | Thore Falkvall | Determination of slag products in dialysis fluid by means of optical sensor |
US6177049B1 (en) | 1998-06-10 | 2001-01-23 | Dsu Medical Corporation | Reversing flow blood processing system |
US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
US6593747B2 (en) | 1998-10-05 | 2003-07-15 | The University Of Western Ontario | Method and apparatus for monitoring adsorbent activity in situ |
CA2533850C (en) | 1998-10-29 | 2009-09-01 | Medtronic Minimed, Inc. | Reservoir connector |
US6248093B1 (en) | 1998-10-29 | 2001-06-19 | Minimed Inc. | Compact pump drive system |
WO2000038761A2 (en) | 1998-12-24 | 2000-07-06 | Fresenius Medical Care Deutschland Gmbh | Method for determining the volume of distribution of a blood component during a blood treatment, and device |
GB9828696D0 (en) | 1998-12-29 | 1999-02-17 | Houston J G | Blood-flow tubing |
US6254567B1 (en) | 1999-02-26 | 2001-07-03 | Nxstage Medical, Inc. | Flow-through peritoneal dialysis systems and methods with on-line dialysis solution regeneration |
US6274103B1 (en) | 1999-03-26 | 2001-08-14 | Prismedical Corporation | Apparatus and method for preparation of a peritoneal dialysis solution |
US6230059B1 (en) | 1999-03-17 | 2001-05-08 | Medtronic, Inc. | Implantable monitor |
SE9901165D0 (en) | 1999-03-30 | 1999-03-30 | Gambro Lundia Ab | Method, apparatus and components of dialysis systems |
DE60025716T2 (en) | 1999-04-30 | 2006-10-19 | Children's Hospital Medical Center, Cincinnati | hemofiltration |
EP1072282A1 (en) | 1999-07-19 | 2001-01-31 | EndoArt S.A. | Flow control device |
US6491993B1 (en) | 1999-08-12 | 2002-12-10 | Pactiv Corporation | Absorbent pouches |
DE19938691A1 (en) | 1999-08-14 | 2001-02-15 | Volkswagen Ag | Traffic-guided influencing and/or support of motor vehicles involves detecting objects, including relative speed, using distance measurements to detect traffic situations |
US6272377B1 (en) | 1999-10-01 | 2001-08-07 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with arrhythmia prediction and prevention |
WO2001051117A1 (en) | 2000-01-11 | 2001-07-19 | Blatter Duane D | Vascular occlusal balloons and related vascular access devices and systems |
US6602399B1 (en) | 2000-03-22 | 2003-08-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften E.V. | Signal recording of a receptor-effector-system by an extracellular planar potential-sensitive electrode |
US20010041869A1 (en) | 2000-03-23 | 2001-11-15 | Causey James D. | Control tabs for infusion devices and methods of using the same |
IL136079A0 (en) | 2000-04-19 | 2001-05-20 | Cheetah Medical Inc C O Pepper | Method and apparatus for monitoring the cardiovascular condition, particularly the degree of arteriosclerosis in individuals |
AU2001259469A1 (en) | 2000-05-05 | 2001-11-20 | Hemocleanse, Inc. | Use of magnetic particles or other particles having relatively high density in afluid for mixing and/or leak detection |
US6890315B1 (en) | 2000-05-23 | 2005-05-10 | Chf Solutions, Inc. | Method and apparatus for vein fluid removal in heart failure |
US6589229B1 (en) | 2000-07-31 | 2003-07-08 | Becton, Dickinson And Company | Wearable, self-contained drug infusion device |
US6585675B1 (en) | 2000-11-02 | 2003-07-01 | Chf Solutions, Inc. | Method and apparatus for blood withdrawal and infusion using a pressure controller |
US7033498B2 (en) | 2000-11-28 | 2006-04-25 | Renal Solutions, Inc. | Cartridges useful in cleaning dialysis solutions |
US6627164B1 (en) | 2000-11-28 | 2003-09-30 | Renal Solutions, Inc. | Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same |
AU2156402A (en) | 2000-12-12 | 2002-06-24 | Jurag Separation Aps | A method and apparatus for isolation of ionic species from a liquid |
WO2002053209A1 (en) | 2000-12-27 | 2002-07-11 | Philips Japan, Ltd. | Biological information and blood treating device information control system, biological information and blood treating device information control device, and biological information and blood treating device information control method |
US6579460B1 (en) | 2001-03-13 | 2003-06-17 | Uop Llc | Process and composition for removing toxins from bodily fluids |
US6773412B2 (en) | 2001-04-13 | 2004-08-10 | Chf Solutions, Inc. | User interface for blood treatment device |
US7241272B2 (en) | 2001-11-13 | 2007-07-10 | Baxter International Inc. | Method and composition for removing uremic toxins in dialysis processes |
US6960179B2 (en) | 2001-11-16 | 2005-11-01 | National Quality Care, Inc | Wearable continuous renal replacement therapy device |
US7309323B2 (en) | 2001-11-16 | 2007-12-18 | National Quality Care, Inc. | Wearable continuous renal replacement therapy device |
US7871390B2 (en) | 2001-11-16 | 2011-01-18 | Fresenius Medical Care Holdings, Inc. | Enhanced clearance in an artificial kidney incorporating a pulsatile pump |
US20060241543A1 (en) | 2001-11-16 | 2006-10-26 | National Quality Care, Inc. | Method for installing and servicing a wearable continuous renal replacement therapy device |
SE525132C2 (en) | 2001-11-23 | 2004-12-07 | Gambro Lundia Ab | Method of operation of dialysis device |
US6878283B2 (en) | 2001-11-28 | 2005-04-12 | Renal Solutions, Inc. | Filter cartridge assemblies and methods for filtering fluids |
US20030114787A1 (en) | 2001-12-13 | 2003-06-19 | Victor Gura | Wearable peritoneal dialysis system |
US20030113931A1 (en) | 2001-12-14 | 2003-06-19 | Li Pan | Ammonia and ammonium sensors |
US6695807B2 (en) | 2002-01-18 | 2004-02-24 | Dsu Medical, Inc. | Blood flow reversing system |
US6878258B2 (en) | 2002-02-11 | 2005-04-12 | Applied Materials, Inc. | Apparatus and method for removing contaminants from semiconductor copper electroplating baths |
US6711439B1 (en) | 2002-02-14 | 2004-03-23 | Pacesetter, Inc. | Evoked response variability as an indicator of autonomic tone and surrogate for patient condition |
JP3820163B2 (en) | 2002-02-22 | 2006-09-13 | 三井化学株式会社 | Urea concentration measuring method and apparatus |
US7076299B2 (en) | 2002-03-28 | 2006-07-11 | Tran Thong | Method and apparatus for preventing heart tachyarrhythmia |
US6878285B2 (en) | 2002-04-17 | 2005-04-12 | Watervisions International, Inc. | Ion-exchange based fluid treatment systems |
US7153286B2 (en) | 2002-05-24 | 2006-12-26 | Baxter International Inc. | Automated dialysis system |
JP4890761B2 (en) | 2002-07-19 | 2012-03-07 | バクスター・インターナショナル・インコーポレイテッド | System and method for performing peritoneal dialysis |
EP1523347B1 (en) | 2002-07-19 | 2011-05-18 | Baxter International Inc. | Systems and methods for performing peritoneal dialysis |
WO2004009156A2 (en) | 2002-07-19 | 2004-01-29 | Baxter International Inc. | Systems and methods for peritoneal dialysis |
ES2245723T5 (en) | 2002-09-05 | 2013-09-10 | Gambro Lundia Ab | Controller for a blood treatment equipment |
US6945640B2 (en) | 2002-09-11 | 2005-09-20 | Inke Pte. Ltd. | Refill station |
US7144384B2 (en) | 2002-09-30 | 2006-12-05 | Insulet Corporation | Dispenser components and methods for patient infusion device |
US7128727B2 (en) | 2002-09-30 | 2006-10-31 | Flaherty J Christopher | Components and methods for patient infusion device |
WO2004039436A1 (en) | 2002-10-30 | 2004-05-13 | Gambro Lundia Ab | A method and an apparatus for determining the efficiency of dialysis |
US20040099593A1 (en) | 2002-11-25 | 2004-05-27 | Potito De Paolis | Concurrent dialysate purification cartridge |
US7060190B2 (en) | 2003-02-27 | 2006-06-13 | King Technology | Dual dispenser |
WO2004062710A2 (en) | 2003-01-07 | 2004-07-29 | Nxstage Medical Inc. | Batch filtration system for preparation of sterile replacement fluid for renal therapy |
US7686778B2 (en) | 2003-01-15 | 2010-03-30 | Nxstage Medical, Inc. | Waste balancing for extracorporeal blood treatment systems |
US7276042B2 (en) | 2003-01-23 | 2007-10-02 | National Quality Care, Inc. | Low hydraulic resistance cartridge |
US6861473B2 (en) | 2003-02-28 | 2005-03-01 | Baxter International Inc. | Macromolecular ketoaldehydes |
US7326576B2 (en) | 2003-04-09 | 2008-02-05 | Prescient Medical, Inc. | Raman spectroscopic monitoring of hemodialysis |
DE10317024A1 (en) | 2003-04-11 | 2004-11-11 | Fresenius Medical Care Deutschland Gmbh | Blood treatment device |
US7330750B2 (en) | 2003-04-25 | 2008-02-12 | Instrumentarium Corp. | Estimation of cardiac death risk |
US7169303B2 (en) | 2003-05-28 | 2007-01-30 | Hemocleanse Technologies, Llc | Sorbent reactor for extracorporeal blood treatment systems, peritoneal dialysis systems, and other body fluid treatment systems |
EP1506809A1 (en) | 2003-08-11 | 2005-02-16 | Boehringer Ingelheim Pharma GmbH & Co. KG | Regeneration of hydrolysis sensitive adsorbent matrices |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US8026729B2 (en) | 2003-09-16 | 2011-09-27 | Cardiomems, Inc. | System and apparatus for in-vivo assessment of relative position of an implant |
US20050065760A1 (en) | 2003-09-23 | 2005-03-24 | Robert Murtfeldt | Method for advising patients concerning doses of insulin |
US7029456B2 (en) | 2003-10-15 | 2006-04-18 | Baxter International Inc. | Medical fluid therapy flow balancing and synchronization system |
EP1680155B2 (en) | 2003-10-28 | 2015-11-04 | Baxter International Inc. | Dialysis machine with improved integrity test |
ATE494022T1 (en) | 2003-10-31 | 2011-01-15 | Gambro Lundia Ab | CIRCUIT FOR EXTRACORPORAL BLOOD TREATMENT AND FLOW REVERSAL DEVICE USED |
US8029454B2 (en) | 2003-11-05 | 2011-10-04 | Baxter International Inc. | High convection home hemodialysis/hemofiltration and sorbent system |
US7776006B2 (en) | 2003-11-05 | 2010-08-17 | Baxter International Inc. | Medical fluid pumping system having real time volume determination |
FR2862204B1 (en) | 2003-11-13 | 2006-02-10 | Yves Vincent Brottier | ELECTRIC DISCHARGE CLEANING APPARATUS IN A CURRENT FLASH LAMP |
EP1691862A1 (en) | 2003-11-20 | 2006-08-23 | Gambro Lundia AB | Method, apparatus and software program for measurement of a parameter relating to a heart-lung system of a mammal. |
US7744553B2 (en) | 2003-12-16 | 2010-06-29 | Baxter International Inc. | Medical fluid therapy flow control systems and methods |
CA2575731C (en) | 2003-12-24 | 2014-07-15 | Chemica Technologies, Inc. | Dialysate regeneration system for portable human dialysis |
DE102004013814A1 (en) | 2004-03-20 | 2005-10-13 | B. Braun Medizintechnologie Gmbh | A method of allowing operator input on a medical device |
US20050234354A1 (en) | 2004-04-15 | 2005-10-20 | Rowlandson G I | System and method for assessing a patient's risk of sudden cardiac death |
US7303540B2 (en) | 2004-04-26 | 2007-12-04 | Chf Solutions, Inc. | User interface for blood treatment device |
US7776210B2 (en) | 2004-06-09 | 2010-08-17 | Renal Solutions, Inc. | Dialysis system |
ITMO20040191A1 (en) | 2004-07-23 | 2004-10-23 | Gambro Lundia Ab | MACHINE AND METHOD FOR EXTRA-BODY BLOOD TREATMENT. |
US7356366B2 (en) | 2004-08-02 | 2008-04-08 | Cardiac Pacemakers, Inc. | Device for monitoring fluid status |
US7219596B2 (en) | 2004-08-19 | 2007-05-22 | Carrier Commerical Refrigeration, Inc. | Coffee brewer with loading and ejection mechanism for a coffee cartridge |
JP4868772B2 (en) | 2004-08-24 | 2012-02-01 | 日機装株式会社 | Blood purification equipment |
US7615028B2 (en) | 2004-12-03 | 2009-11-10 | Chf Solutions Inc. | Extracorporeal blood treatment and system having reversible blood pumps |
CN101090772A (en) | 2004-12-28 | 2007-12-19 | 雷纳尔溶液公司 | Method of synthesizing zirconium phosphate particles |
US7756572B1 (en) | 2005-01-25 | 2010-07-13 | Pacesetter, Inc. | System and method for efficiently distinguishing among cardiac ischemia, hypoglycemia and hyperglycemia using an implantable medical device and an external system |
US8903492B2 (en) | 2005-02-07 | 2014-12-02 | Medtronic, Inc. | Ion imbalance detector |
US20060189926A1 (en) | 2005-02-14 | 2006-08-24 | Hall W D | Apparatus and methods for analyzing body fluid samples |
US20060195064A1 (en) | 2005-02-28 | 2006-08-31 | Fresenius Medical Care Holdings, Inc. | Portable apparatus for peritoneal dialysis therapy |
JP4726045B2 (en) | 2005-04-08 | 2011-07-20 | 日機装株式会社 | Hemodialysis machine |
CA2651357C (en) | 2005-05-06 | 2014-09-02 | Imi Vision Limited | Dialysis machine |
US7641649B2 (en) | 2005-05-06 | 2010-01-05 | Medtronic Minimed, Inc. | Reservoir support and method for infusion device |
ES2348407T3 (en) | 2005-05-18 | 2010-12-03 | Gambro Lundia Ab | APPLIANCE TO CONTROL THE BLOOD FLOW IN AN EXTRACORPORE CIRCUIT. |
CN101180089B (en) | 2005-05-23 | 2010-12-08 | 旭化成可乐丽医疗株式会社 | Body fluid treating filter device |
JP2007044602A (en) | 2005-08-09 | 2007-02-22 | Kanto Chem Co Inc | Catalyst carrier, metal fixed catalyst, production method thereof, and method for oxidizing alcohol using the same |
US7674231B2 (en) | 2005-08-22 | 2010-03-09 | Massachusetts Institute Of Technology | Wearable pulse wave velocity blood pressure sensor and methods of calibration thereof |
US8372025B2 (en) | 2005-09-22 | 2013-02-12 | Baxter International Inc. | Automation and optimization of CRRT treatment using regional citrate anticoagulation |
JP4968074B2 (en) | 2005-10-18 | 2012-07-04 | 株式会社ジェイ・エム・エス | Peritoneal function test apparatus and peritoneal function test program |
US20100137693A1 (en) | 2005-11-01 | 2010-06-03 | Fresenius Medical Care Holdings, Inc. | Methods and systems for patient care |
DE102005060866B4 (en) | 2005-12-20 | 2009-01-15 | Bruker Biospin Gmbh | Combined titration and pH electrode for the preparation of liquid samples, especially for NMR spectroscopy |
EP1971650A2 (en) | 2005-12-22 | 2008-09-24 | E.I. Du Pont De Nemours And Company | Methods to prepare chemically stabilized ionomers containing inorganic fillers |
US8187250B2 (en) | 2006-01-30 | 2012-05-29 | The Regents Of The University Of California | Peritoneal dialysis methods and apparatus |
US8246563B2 (en) | 2006-02-02 | 2012-08-21 | Cardiac Pacemakers, Inc. | Cardiac rhythm management device and sensor-suite for the optimal control of ultrafiltration and renal replacement therapies |
JP5254043B2 (en) | 2006-02-22 | 2013-08-07 | ヘンリー フォード ヘルス システム | Topical citrate anticoagulant delivery system and method to extracorporeal blood circuit |
US8012118B2 (en) | 2006-03-08 | 2011-09-06 | Fresenius Medical Care Holdings, Inc. | Artificial kidney dialysis system |
US8715221B2 (en) | 2006-03-08 | 2014-05-06 | Fresenius Medical Care Holdings, Inc. | Wearable kidney |
US7785463B2 (en) | 2006-03-17 | 2010-08-31 | Children's Hospital Medical Center | Extracorporeal renal replacement modeling system |
US20070243113A1 (en) | 2006-04-12 | 2007-10-18 | Dileo Anthony | Filter with memory, communication and concentration sensor |
CA2970214C (en) | 2006-04-14 | 2021-08-17 | Deka Products Limited Partnership | System for pumping a biological fluid |
US8366316B2 (en) | 2006-04-14 | 2013-02-05 | Deka Products Limited Partnership | Sensor apparatus systems, devices and methods |
US7942844B2 (en) | 2006-04-28 | 2011-05-17 | Medtronic Minimed, Inc. | Remote monitoring for networked fluid infusion systems |
US8226595B2 (en) | 2006-05-26 | 2012-07-24 | Baxter International Inc. | Automated dialysis system driven by gravity and vacuum |
US7572232B2 (en) | 2006-07-24 | 2009-08-11 | Cardiac Pacemakers, Inc. | Cardiac signal display and event detection using multiresolution Z-score transform |
SE532971C2 (en) | 2006-08-16 | 2010-05-25 | Triomed Ab | Liquid regeneration system |
US7887502B2 (en) | 2006-09-15 | 2011-02-15 | University Of Florida Research Foundation, Inc. | Method for using photoplethysmography to optimize fluid removal during renal replacement therapy by hemodialysis or hemofiltration |
US8831717B2 (en) | 2006-09-19 | 2014-09-09 | Gambro Lundia Ab | Estimation of propensity to symptomatic hypotension |
GB0621452D0 (en) | 2006-10-27 | 2006-12-06 | Ucl Business Plc | Therapy for liver disease |
CA2671010C (en) | 2006-12-01 | 2012-04-24 | Gambro Lundia Ab | Blood treatment apparatus |
US20110247973A1 (en) | 2006-12-08 | 2011-10-13 | Ohio University | Exfiltration apparatus |
US8109893B2 (en) | 2006-12-19 | 2012-02-07 | Lande Arnold J | Chronic access system for extracorporeal treatment of blood including a continously wearable hemodialyzer |
US9033908B2 (en) | 2006-12-21 | 2015-05-19 | Nederlandse Organisatie Voor Toegepast—Natuurwetenschappelijk Onderzoek Tno | Device for the removal of toxic substances from blood |
US9968266B2 (en) | 2006-12-27 | 2018-05-15 | Cardiac Pacemakers, Inc. | Risk stratification based heart failure detection algorithm |
US20080161751A1 (en) | 2006-12-29 | 2008-07-03 | Plahey Kulwinder S | Peritoneal dialysis therapy validation |
US8183046B2 (en) | 2007-01-11 | 2012-05-22 | The Board Of Trustees Of The University Of Illinois | Temperature resistant pH buffers for use at low temperatures |
EP2131889B1 (en) | 2007-02-27 | 2019-01-02 | Deka Products Limited Partnership | Hemodialysis systems and methods |
US8042563B2 (en) | 2007-02-27 | 2011-10-25 | Deka Products Limited Partnership | Cassette system integrated apparatus |
US8409441B2 (en) | 2007-02-27 | 2013-04-02 | Deka Products Limited Partnership | Blood treatment systems and methods |
US20080253911A1 (en) | 2007-02-27 | 2008-10-16 | Deka Products Limited Partnership | Pumping Cassette |
US8357298B2 (en) | 2007-02-27 | 2013-01-22 | Deka Products Limited Partnership | Hemodialysis systems and methods |
US7906085B2 (en) | 2007-03-30 | 2011-03-15 | Battelle Memorial Institute | Fast-regenerable sulfur dioxide adsorbents for diesel engine emission control |
WO2008125894A1 (en) | 2007-04-12 | 2008-10-23 | Gambro Lundia Ab | Apparatus for extracorporeal blood treatment |
US8529487B2 (en) | 2007-04-12 | 2013-09-10 | Gambro Lundia Ab | Method and apparatus for priming an extracorporeal blood circuit |
DE602007008544D1 (en) | 2007-06-20 | 2010-09-30 | Braun B Avitum Ag | Device for determining the reduction ratio or the Kt / V ratio of renal replacement therapy |
US7901376B2 (en) | 2007-07-05 | 2011-03-08 | Baxter International Inc. | Dialysis cassette having multiple outlet valve |
CN101541957B (en) | 2007-07-20 | 2013-08-14 | 梅约医学教育与研究基金会 | Natriuretic polypeptides |
US7981082B2 (en) | 2007-08-21 | 2011-07-19 | Hospira, Inc. | System and method for reducing air bubbles in a fluid delivery line |
AT505690B1 (en) | 2007-08-31 | 2012-09-15 | Zentrum Fuer Biomedizinische Technologie Der Donau Uni Krems | METHOD OF DETERMINING ION CONCENTRATION IN CITRATE ANTICOAGULATED EXTRACORPORAL BLOOD CLEANING |
US20090101577A1 (en) | 2007-09-28 | 2009-04-23 | Fulkerson Barry N | Methods and Systems for Controlling Ultrafiltration Using Central Venous Pressure Measurements |
US8105487B2 (en) | 2007-09-25 | 2012-01-31 | Fresenius Medical Care Holdings, Inc. | Manifolds for use in conducting dialysis |
US9199022B2 (en) | 2008-09-12 | 2015-12-01 | Fresenius Medical Care Holdings, Inc. | Modular reservoir assembly for a hemodialysis and hemofiltration system |
US8597505B2 (en) | 2007-09-13 | 2013-12-03 | Fresenius Medical Care Holdings, Inc. | Portable dialysis machine |
US20090084199A1 (en) | 2007-09-28 | 2009-04-02 | Wright James E | Quick-change sorbent trap module and method |
US7892331B2 (en) | 2007-10-01 | 2011-02-22 | Baxter International Inc. | Dialysis systems having air separation chambers with internal structures to enhance air removal |
US20090120864A1 (en) | 2007-10-05 | 2009-05-14 | Barry Neil Fulkerson | Wearable dialysis methods and devices |
US8771508B2 (en) | 2008-08-27 | 2014-07-08 | Deka Products Limited Partnership | Dialyzer cartridge mounting arrangement for a hemodialysis system |
US7905853B2 (en) | 2007-10-30 | 2011-03-15 | Baxter International Inc. | Dialysis system having integrated pneumatic manifold |
US9415150B2 (en) | 2007-11-09 | 2016-08-16 | Baxter Healthcare S.A. | Balanced flow dialysis machine |
US8889004B2 (en) | 2007-11-16 | 2014-11-18 | Fresenius Medical Care Holdings, Inc. | Dialysis systems and methods |
EP2263715B1 (en) | 2007-11-16 | 2014-04-30 | Fresenius Medical Care Holdings, Inc. | Dialysis systems |
PT2214752E (en) | 2007-12-03 | 2011-05-03 | Hepa Wash Gmbh | Dialysate regeneration unit |
CN102046260B (en) | 2008-01-18 | 2014-09-24 | 弗雷塞尼斯医疗保健控股公司 | Carbon dioxide gas removal from a fluid circuit of a dialysis device |
EP2252347B1 (en) | 2008-01-23 | 2016-07-20 | DEKA Products Limited Partnership | Fluid volume determination for medical treatment system |
US7687041B2 (en) | 2008-02-27 | 2010-03-30 | Kellogg Brown & Root Llc | Apparatus and methods for urea production |
US8019406B2 (en) | 2008-03-10 | 2011-09-13 | Biotronik Crm Patent Ag | Apparatus and method to assess the risk of R-on-T event |
CN102046234A (en) | 2008-03-28 | 2011-05-04 | 阿兰德拉医药公司 | Cartridges of liquid anaesthetic and vaporiser |
EP2274083A1 (en) | 2008-04-30 | 2011-01-19 | Gambro Lundia AB | Hydrophobic deaeration membrane |
US8233973B2 (en) | 2008-05-02 | 2012-07-31 | Spacelabs Healthcare, Llc | Methods for detection of cardiac arrhythmias |
US8882700B2 (en) | 2008-05-02 | 2014-11-11 | Baxter International Inc. | Smart patient transfer set for peritoneal dialysis |
US8220643B2 (en) | 2008-06-06 | 2012-07-17 | Fresenius Medical Care Holdings, Inc. | Urea sorbent |
BRPI0915397B8 (en) | 2008-06-23 | 2021-06-22 | Temasek Polytechnic | sorbent for a dialysis device |
US9821105B2 (en) | 2008-07-01 | 2017-11-21 | Baxter International Inc. | Nanoclay sorbents for dialysis |
JP5172508B2 (en) | 2008-07-09 | 2013-03-27 | 株式会社ジャパンディスプレイセントラル | Liquid crystal display |
US8057679B2 (en) | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
US10265454B2 (en) | 2008-07-25 | 2019-04-23 | Baxter International Inc. | Dialysis system with flow regulation device |
US8696626B2 (en) | 2008-07-30 | 2014-04-15 | Claudia F. E. Kirsch | Debubbler |
WO2010025382A2 (en) | 2008-08-28 | 2010-03-04 | Deka Products Limited Partnership | Product dispensing system |
US20100051552A1 (en) | 2008-08-28 | 2010-03-04 | Baxter International Inc. | In-line sensors for dialysis applications |
EP2163272B1 (en) | 2008-09-15 | 2014-06-25 | B. Braun Avitum AG | Device to early predict the Kt/V parameter in kidney substitution treatments |
CA2735452C (en) | 2008-09-30 | 2022-02-01 | Fresenius Medical Care Holdings, Inc. | Covalently immobilized enzyme and method to make the same |
US8409444B2 (en) | 2008-09-30 | 2013-04-02 | Fresenius Medical Care Holdings, Inc. | Acid zirconium phosphate and alkaline hydrous zirconium oxide materials for sorbent dialysis |
WO2010039721A2 (en) | 2008-10-03 | 2010-04-08 | Fresenius Medical Care Holdings, Inc. | Zirconium phosphate particles having improved adsorption capacity and method of synthesizing the same |
US8206591B2 (en) | 2008-10-16 | 2012-06-26 | Fresenius Medical Care Holdings, Inc. | Method of removing protein-bound deleterious substances during extracorporeal renal replacement treatment |
CN101725811A (en) | 2008-10-24 | 2010-06-09 | 鸿富锦精密工业(深圳)有限公司 | Supporting device |
US7927392B2 (en) | 2008-10-28 | 2011-04-19 | Bha Group, Inc. | Twist and lock connection for pleated filter element with flange-to-flange locking means |
EP2344220B1 (en) | 2008-11-03 | 2013-04-24 | Fresenius Medical Care Holdings, Inc. | Portable peritoneal dialysis system |
US8182673B2 (en) | 2009-01-29 | 2012-05-22 | Baxter International Inc. | Drain and fill logic for automated peritoneal dialysis |
US8377012B2 (en) | 2009-01-30 | 2013-02-19 | Baxter International Inc. | Transfer sets for therapy optimization |
EP2403554B1 (en) | 2009-03-06 | 2017-07-05 | Baxter International Inc. | Hemodialysis and peritoneal dialysis systems having electrodeionization capabilities |
US20100312172A1 (en) | 2009-06-06 | 2010-12-09 | Hoffman Josef C A | Method of Peritoneal Dialysis |
US20100312174A1 (en) | 2009-06-06 | 2010-12-09 | Hoffman Josef C A | Peritoneal Dialysis System |
US8080161B2 (en) | 2009-06-11 | 2011-12-20 | Baxter International Inc. | Dialysis treatment devices for removing urea |
AU2010264669C1 (en) | 2009-06-26 | 2015-04-30 | Gambro Lundia Ab | Devices, a computer program product and a method for data extraction |
WO2011002850A1 (en) | 2009-07-01 | 2011-01-06 | Board Or Regents, The University Of Texas System | Methods of determining the presence and/or concentration of an analyte in a sample |
US8180574B2 (en) | 2009-07-07 | 2012-05-15 | Baxter International | Simplified peritoneal equilibration test for peritoneal dialysis |
EP2461843B1 (en) | 2009-08-04 | 2016-03-02 | Fresenius Medical Care Holdings, Inc. | Dialysis systems, components, and methods |
US8404091B2 (en) | 2009-08-27 | 2013-03-26 | Baxter International Inc. | Dialysis treatment devices for removing urea |
US20110066043A1 (en) | 2009-09-14 | 2011-03-17 | Matt Banet | System for measuring vital signs during hemodialysis |
US9399091B2 (en) | 2009-09-30 | 2016-07-26 | Medtronic, Inc. | System and method to regulate ultrafiltration |
US8518260B2 (en) | 2009-10-01 | 2013-08-27 | Fresenius Medical Care Holdings, Inc. | Method of controlling diffusive sodium transport in dialysis |
US20110130666A1 (en) | 2009-11-30 | 2011-06-02 | Yanting Dong | Enhanced reporting of pathological episodes |
AU2010328630B2 (en) | 2009-12-07 | 2014-05-15 | Fresenius Medical Care Holdings, Inc. | Water purification cartridge using zirconium ion-exchange sorbents |
US10980431B2 (en) | 2009-12-28 | 2021-04-20 | Gambro Lundia Ab | Apparatus and method for prediction of rapid symptomatic blood pressure decrease |
BR112012016793A2 (en) | 2010-01-08 | 2018-07-31 | Zafgen Corp | fumagilol-like compounds and methods of making and using them |
JP5442483B2 (en) | 2010-02-10 | 2014-03-12 | 日機装株式会社 | Blood purification equipment |
CN102190336B (en) | 2010-03-08 | 2014-11-26 | 周耀周 | Fluid treatment unit, fluid treatment component, and fluid treatment apparatus |
US8425780B2 (en) | 2010-03-11 | 2013-04-23 | Fresenius Medical Care Holdings, Inc. | Dialysis system venting devices and related systems and methods |
DE102010003642A1 (en) | 2010-03-15 | 2011-09-15 | Fresenius Medical Care Deutschland Gmbh | Cassette with a sensor for determining the difference between a first and a second liquid flow |
JP5548001B2 (en) | 2010-03-25 | 2014-07-16 | 日機装株式会社 | Blood purification equipment |
DE102010014785A1 (en) | 2010-04-13 | 2011-10-13 | Fresenius Medical Care Deutschland Gmbh | Multilayer film, use of a multilayer film and method for producing a multilayer film |
US9132219B2 (en) | 2010-04-16 | 2015-09-15 | Baxter International Inc. | Therapy prediction and optimization of serum potassium for renal failure blood therapy, especially home hemodialysis |
US20110272337A1 (en) | 2010-05-04 | 2011-11-10 | C-Tech Biomedical, Inc. | Dual mode hemodialysis machine |
US20110272352A1 (en) | 2010-05-05 | 2011-11-10 | C-Tech Biomedical, Inc. | Membrane electrolyzer and hemodialysis system using the same |
DE102010020838A1 (en) | 2010-05-18 | 2011-11-24 | Fresenius Medical Care Deutschland Gmbh | Valve assembly for use in extracorporeal blood circulation and method |
US20110315632A1 (en) | 2010-05-24 | 2011-12-29 | Freije Iii William F | Membrane filtration system |
EP2576453B1 (en) | 2010-05-24 | 2018-08-22 | Baxter International Inc. | Systems and methods for removing hydrogen peroxide from water purification systems |
DE102010023635A1 (en) | 2010-06-14 | 2011-12-15 | Fresenius Medical Care Deutschland Gmbh | Device and method for conveying liquids into the treatment unit of a medical treatment device, in particular into the dialyzer of a dialysis machine |
US9636445B2 (en) | 2010-07-05 | 2017-05-02 | Gambro Lundia Ab | Ambulatory ultrafiltration device with control unit programmed to control a drive fluid pump to perform ultrafiltration |
US8784668B2 (en) | 2010-10-12 | 2014-07-22 | Fresenius Medical Care Holdings, Inc. | Systems and methods for compensation of compliant behavior in regenerative dialysis systems |
DE102010042637A1 (en) | 2010-10-19 | 2012-04-19 | Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik GmbH + Co. KG | conductivity sensor |
US8404491B2 (en) | 2010-10-29 | 2013-03-26 | Hewlett-Packard Development Company, L.P. | Luminescent chemical sensor integrated with at least one molecular trap |
EP2446908B1 (en) | 2010-11-02 | 2015-07-15 | ICinnovation BV | Electrosorption and decomposition device for the purification of blood and other fluids |
US9694125B2 (en) | 2010-12-20 | 2017-07-04 | Fresenius Medical Care Holdings, Inc. | Medical fluid cassettes and related systems and methods |
EP2678028A2 (en) | 2011-02-25 | 2014-01-01 | Medtronic, Inc. | Systems and methods for therapy of kidney disease and/or heart failure using chimeric natriuretic peptides |
US9161675B2 (en) | 2011-03-09 | 2015-10-20 | Bsh Home Appliances Corporation | Household appliance including information light device |
ITMI20110441A1 (en) | 2011-03-21 | 2012-09-22 | Gambro Lundia Ab | EQUIPMENT FOR EXTRACORPROUS TREATMENT OF BLOOD. |
US8945936B2 (en) | 2011-04-06 | 2015-02-03 | Fresenius Medical Care Holdings, Inc. | Measuring chemical properties of a sample fluid in dialysis systems |
US20120258546A1 (en) | 2011-04-08 | 2012-10-11 | Life Technologies Corporation | Automated On-Instrument pH Adjustment |
US9456755B2 (en) | 2011-04-29 | 2016-10-04 | Medtronic, Inc. | Method and device to monitor patients with kidney disease |
US9848778B2 (en) | 2011-04-29 | 2017-12-26 | Medtronic, Inc. | Method and device to monitor patients with kidney disease |
EP2701758A1 (en) | 2011-04-29 | 2014-03-05 | Medtronic, Inc. | Multimodal dialysis system |
WO2012148784A2 (en) | 2011-04-29 | 2012-11-01 | Medtronic, Inc. | Method and device to monitor patients with kidney disease |
US9320842B2 (en) | 2011-04-29 | 2016-04-26 | Medtronic, Inc. | Multimodal dialysis system |
US9132217B2 (en) | 2011-04-29 | 2015-09-15 | Medtronic, Inc. | Multimodal dialysis system |
US9700661B2 (en) | 2011-04-29 | 2017-07-11 | Medtronic, Inc. | Chronic pH or electrolyte monitoring |
US20120303079A1 (en) | 2011-05-23 | 2012-11-29 | Deepa Mahajan | Apparatus and method for combined cardiac function management and renal therapies |
SG10201800720YA (en) | 2011-05-24 | 2018-03-28 | Deka Products Lp | Blood treatment systems and methods |
EP2714134B1 (en) | 2011-05-24 | 2017-05-10 | DEKA Products Limited Partnership | Hemodialysis system |
US20130019179A1 (en) | 2011-07-14 | 2013-01-17 | Digilink Software, Inc. | Mobile application enhancements |
WO2013015858A1 (en) | 2011-07-26 | 2013-01-31 | Eveready Battery Company, Inc. | Hydrogen generator with improved fluid distribution |
DE102011052188A1 (en) | 2011-07-27 | 2013-01-31 | Maquet Vertrieb Und Service Deutschland Gmbh | Arrangement for removing carbon dioxide from blood flow or for enriching blood flow with oxygen, has filter, which has membrane, where membrane separates blood region, through which blood flow is guided |
DE102011108786A1 (en) | 2011-07-29 | 2013-01-31 | Fresenius Medical Care Deutschland Gmbh | Method for determining at least one parameter of extracorporeal blood circulation and devices |
US20130030356A1 (en) | 2011-07-29 | 2013-01-31 | Baxter Healthcare S.A. | Sodium management for dialysis systems |
WO2013019179A1 (en) | 2011-07-29 | 2013-02-07 | Baxter International Inc. | Sodium management for dialysis systems |
DE102011108787A1 (en) | 2011-07-29 | 2013-01-31 | Fresenius Medical Care Deutschland Gmbh | Medical port, blood tube for use in extracorporeal blood treatment and medical treatment device |
CN103889481B (en) | 2011-08-02 | 2016-03-09 | 美敦力公司 | With the hemodialysis system of flow path with controlled compliance volume |
US20130037142A1 (en) | 2011-08-08 | 2013-02-14 | Fresenius Medical Care Holdings, Inc. | Dialysis system having peristaltic pump arrangement |
JP6002136B2 (en) | 2011-08-09 | 2016-10-05 | 川澄化学工業株式会社 | Blood purification equipment |
US10857277B2 (en) | 2011-08-16 | 2020-12-08 | Medtronic, Inc. | Modular hemodialysis system |
AU2012296410B2 (en) | 2011-08-18 | 2015-05-07 | Fresenius Medical Care Holdings, Inc. | Sorbent and chemical regeneration of dialysate |
WO2013027214A2 (en) | 2011-08-22 | 2013-02-28 | Bar-Ilan University | Nanop article dialysis |
US9707330B2 (en) | 2011-08-22 | 2017-07-18 | Medtronic, Inc. | Dual flow sorbent cartridge |
EP2564884B1 (en) | 2011-08-30 | 2014-06-18 | Gambro Lundia AB | Medical apparatus for extracorporeal treatment of fluid and a process of calculating set flow rates in a medical apparatus for delivery or collection of fluids |
EP3799897A1 (en) | 2011-08-30 | 2021-04-07 | Gambro Lundia AB | Apparatus for extracorporeal treatment of blood |
DE102011053200A1 (en) | 2011-09-01 | 2013-03-07 | Fresenius Medical Care Deutschland Gmbh | Dialysate flow control |
JP5099464B1 (en) | 2011-12-29 | 2012-12-19 | 富田製薬株式会社 | Bicarbonate ion concentration-variable dialysate preparation device and preparation method, bicarbonate ion concentration-variable dialysate, and bicarbonate ion concentration-variable dialyzing system |
CN104039439B (en) | 2011-12-29 | 2017-06-13 | 费森尤斯医疗保健集团 | For removing the material of the toxin in adsorbent dialysis and using its method and system |
EP2800591B1 (en) | 2012-01-04 | 2016-01-13 | Fresenius Medical Care Holdings, Inc. | Method and system of enhancing removal of toxic anions and organic solutes in sorbent dialysis |
WO2013103906A1 (en) | 2012-01-04 | 2013-07-11 | Medtronic, Inc. | Multi-staged filtration system for blood fluid removal |
WO2013109922A1 (en) | 2012-01-19 | 2013-07-25 | Baxter International Inc. | Method and composition for removing uremic toxins in dialysis processes |
WO2013114063A1 (en) | 2012-02-02 | 2013-08-08 | Quanta Fluid Solutions Ltd. | Dialysis machine |
EP2814535B1 (en) | 2012-02-14 | 2018-05-30 | Quanta Dialysis Technologies Limited | Dialysis machine |
JP5629714B2 (en) | 2012-03-19 | 2014-11-26 | トヨタ自動車株式会社 | Semiconductor device |
US9610392B2 (en) | 2012-06-08 | 2017-04-04 | Fresenius Medical Care Holdings, Inc. | Medical fluid cassettes and related systems and methods |
US9500188B2 (en) | 2012-06-11 | 2016-11-22 | Fresenius Medical Care Holdings, Inc. | Medical fluid cassettes and related systems and methods |
US9231692B2 (en) | 2012-09-04 | 2016-01-05 | Viasat Inc. | Paired-beam transponder satellite communication |
US9162021B2 (en) | 2012-10-22 | 2015-10-20 | Baxter International Inc. | Integrated water testing system and method for ultra-low total chlorine detection |
US9138520B2 (en) | 2012-10-22 | 2015-09-22 | Baxter International Inc. | Total chlorine water detection system and method for medical fluid treatments |
JP2014097224A (en) | 2012-11-15 | 2014-05-29 | Tatsunori Kato | Dialysis unit and method for measuring access recirculation rate |
US20140158588A1 (en) | 2012-12-10 | 2014-06-12 | Medtronic, Inc. | pH AND BUFFER MANAGEMENT SYSTEM FOR HEMODIALYSIS SYSTEMS |
US9399090B2 (en) | 2012-12-10 | 2016-07-26 | Medtronic, Inc. | Potassium loaded ion-exchange material for use in a dialysate regeneration system |
US10905816B2 (en) | 2012-12-10 | 2021-02-02 | Medtronic, Inc. | Sodium management system for hemodialysis |
US9707328B2 (en) | 2013-01-09 | 2017-07-18 | Medtronic, Inc. | Sorbent cartridge to measure solute concentrations |
US11154648B2 (en) | 2013-01-09 | 2021-10-26 | Medtronic, Inc. | Fluid circuits for sorbent cartridge with sensors |
US11565029B2 (en) | 2013-01-09 | 2023-01-31 | Medtronic, Inc. | Sorbent cartridge with electrodes |
US9713666B2 (en) | 2013-01-09 | 2017-07-25 | Medtronic, Inc. | Recirculating dialysate fluid circuit for blood measurement |
US9526822B2 (en) | 2013-02-01 | 2016-12-27 | Medtronic, Inc. | Sodium and buffer source cartridges for use in a modular controlled compliant flow path |
WO2014121162A1 (en) | 2013-02-01 | 2014-08-07 | Medtronic, Inc. | Sorbent cartridge to measure solute concentrations |
US10010663B2 (en) | 2013-02-01 | 2018-07-03 | Medtronic, Inc. | Fluid circuit for delivery of renal replacement therapies |
US9144640B2 (en) | 2013-02-02 | 2015-09-29 | Medtronic, Inc. | Sorbent cartridge configurations for improved dialysate regeneration |
US9827361B2 (en) | 2013-02-02 | 2017-11-28 | Medtronic, Inc. | pH buffer measurement system for hemodialysis systems |
US9410255B2 (en) | 2013-03-14 | 2016-08-09 | Tennant Company | System and method for generating and dispensing sodium hydroxide solutions |
WO2015031310A1 (en) | 2013-08-26 | 2015-03-05 | Mason Roger Alan | Improved system and method for administering peritoneal dialysis |
US9707329B2 (en) | 2013-10-23 | 2017-07-18 | Fresenius Medical Care Holdings, Inc. | Process for regeneration of spent zirconium phosphate for reuse in sorbent treatments |
US9943780B2 (en) | 2013-11-26 | 2018-04-17 | Medtronic, Inc. | Module for in-line recharging of sorbent materials with optional bypass |
US10064986B2 (en) | 2013-11-26 | 2018-09-04 | Medtronic, Inc. | Recharger for recharging zirconium phosphate and zirconium oxide modules |
US9981245B2 (en) | 2013-11-26 | 2018-05-29 | Medtronic, Inc. | Method and apparatus for zirconium oxide recharging |
US10099214B2 (en) | 2013-11-26 | 2018-10-16 | Medtronic, Inc. | Zirconium phosphate and zirconium oxide recharger control logic and operational process algorithms |
US9895477B2 (en) | 2013-11-26 | 2018-02-20 | Medtronic, Inc. | Detachable module for recharging sorbent materials with optional bypass |
US10537875B2 (en) | 2013-11-26 | 2020-01-21 | Medtronic, Inc. | Precision recharging of sorbent materials using patient and session data |
US10004839B2 (en) | 2013-11-26 | 2018-06-26 | Medtronic, Inc. | Multi-use sorbent cartridge |
US9974896B2 (en) | 2014-06-24 | 2018-05-22 | Medtronic, Inc. | Method of zirconium phosphate recharging |
US10052612B2 (en) | 2013-11-26 | 2018-08-21 | Medtronic, Inc. | Zirconium phosphate recharging method and apparatus |
US10052624B2 (en) | 2013-11-26 | 2018-08-21 | Medtronic, Inc. | Zirconium phosphate and zirconium oxide recharging flow paths |
US10159957B2 (en) | 2013-11-26 | 2018-12-25 | Medtronic, Inc. | Zirconium phosphate recharging customization |
US9884145B2 (en) | 2013-11-26 | 2018-02-06 | Medtronic, Inc. | Parallel modules for in-line recharging of sorbents using alternate duty cycles |
US10099215B2 (en) | 2013-11-26 | 2018-10-16 | Medtronic, Inc. | Management of recharger effluent pH |
JP6438042B2 (en) | 2014-02-19 | 2018-12-12 | メドトロニック,インコーポレイテッド | Module for refilling adsorbent material inline with optional bypass |
US9764073B2 (en) | 2014-02-26 | 2017-09-19 | Medtronic, Inc. | Authentication and tracking system |
EP3086824B1 (en) | 2014-03-17 | 2018-10-31 | Fresenius Medical Care Holdings, Inc. | Cartridges useful in cleaning dialysis solutions |
US10124274B2 (en) | 2014-06-24 | 2018-11-13 | Medtronic, Inc. | Replenishing urease in dialysis systems using urease pouches |
WO2015199768A1 (en) | 2014-06-24 | 2015-12-30 | Medtronic, Inc. | Stacked sorbent assembly |
US10016553B2 (en) | 2014-06-24 | 2018-07-10 | Medtronic, Inc. | Replenishing urease in dialysis systems using a urease introducer |
WO2015199766A1 (en) | 2014-06-24 | 2015-12-30 | Medtronic, Inc. | Modular dialysate regeneration assembly |
US10286380B2 (en) | 2014-06-24 | 2019-05-14 | Medtronic, Inc. | Sorbent pouch |
WO2015199767A1 (en) | 2014-06-24 | 2015-12-30 | Medtronic, Inc. | Reserve zirconium phosphate module for use in sorbent dialysis |
WO2015199763A1 (en) | 2014-06-24 | 2015-12-30 | Medtronic, Inc. | A urease introduction system for replenishing urease in a sorbent cartridge |
CN107690337B (en) | 2015-05-26 | 2020-02-21 | 美敦力公司 | Zirconium phosphate and zirconium oxide recharging flow paths |
WO2016191039A1 (en) | 2015-05-26 | 2016-12-01 | Medtronic, Inc. | Recharger for recharging zirconium phosphate and zirconium oxide modules |
US20180361355A1 (en) * | 2017-06-15 | 2018-12-20 | Medtronic, Inc. | Zirconium oxide disinfection recharging and conditioning |
EP3546042A1 (en) | 2018-03-30 | 2019-10-02 | Medtronic, Inc. | Precision recharging of sorbent materials using patient and session data |
US20200086297A1 (en) | 2018-09-19 | 2020-03-19 | Medtronic, Inc. | Precision recharging based on sorbent effluent analysis |
-
2017
- 2017-10-30 US US15/798,233 patent/US10981148B2/en active Active
- 2017-11-20 CA CA2986121A patent/CA2986121A1/en active Pending
- 2017-11-23 CN CN201711179516.7A patent/CN108159733B/en active Active
- 2017-11-28 EP EP17203984.4A patent/EP3326668B1/en active Active
-
2021
- 2021-03-10 US US17/197,665 patent/US11642654B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5685835A (en) * | 1995-06-07 | 1997-11-11 | Cobe Laboratories, Inc. | Technique for using a dialysis machine to disinfect a blood tubing set |
US20020147109A1 (en) * | 1999-07-11 | 2002-10-10 | Solmecs (Israel) Ltd. | Sorbent composition |
US20040127648A1 (en) * | 2002-12-31 | 2004-07-01 | Ciphergen Biosystems, Inc. | Sorbent and method for the separation of plasmid DNA |
US10981148B2 (en) * | 2016-11-29 | 2021-04-20 | Medtronic, Inc. | Zirconium oxide module conditioning |
Also Published As
Publication number | Publication date |
---|---|
CN108159733B (en) | 2020-08-07 |
CN108159733A (en) | 2018-06-15 |
EP3326668A1 (en) | 2018-05-30 |
EP3326668B1 (en) | 2020-03-11 |
US20180147558A1 (en) | 2018-05-31 |
US10981148B2 (en) | 2021-04-20 |
CA2986121A1 (en) | 2018-05-29 |
US11642654B2 (en) | 2023-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11642654B2 (en) | Zirconium oxide module conditioning | |
US10099215B2 (en) | Management of recharger effluent pH | |
US10099214B2 (en) | Zirconium phosphate and zirconium oxide recharger control logic and operational process algorithms | |
US20160243541A1 (en) | Zirconium phosphate and zirconium oxide recharging flow paths | |
US10064986B2 (en) | Recharger for recharging zirconium phosphate and zirconium oxide modules | |
EP3302609B1 (en) | Recharger for recharging zirconium phosphate and zirconium oxide modules | |
EP3302610B1 (en) | Zirconium phosphate and zirconium oxide recharging flow paths | |
US10159957B2 (en) | Zirconium phosphate recharging customization | |
US11219880B2 (en) | System for precision recharging of sorbent materials using patient and session data | |
EP3546042A1 (en) | Precision recharging of sorbent materials using patient and session data | |
EP3326712B1 (en) | Zirconium phosphate recharging customization | |
US11213616B2 (en) | Recharge solution for zirconium phosphate | |
US11167070B2 (en) | Ganged modular recharging system | |
EP3302611B1 (en) | Zirconium phosphate and zirconium oxide recharger and control logic | |
US20180361355A1 (en) | Zirconium oxide disinfection recharging and conditioning | |
EP3302607B1 (en) | Management of recharger effluent ph | |
EP3623042B1 (en) | Recharge solution for zirconium oxide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
AS | Assignment |
Owner name: MEDTRONIC, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HOBOT, CHRISTOPHER M.;PUDIL, BRYANT J.;REEL/FRAME:055865/0111 Effective date: 20170209 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
AS | Assignment |
Owner name: MOZARC MEDICAL US LLC, MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEDTRONIC, INC.;REEL/FRAME:063375/0659 Effective date: 20230328 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |